Lawrence F. Eichenfield, MD - Rady Children's Hospital

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.FACULTY APPOINTMENTSProfessor of Clinical Pediatrics and Medicine (Dermatology), Universityof California, San Diego, School of MedicineAdjunct Professor, Departments of Pediatrics and Medicine(Dermatology), University of California, San Diego, School of MedicineClinical Professor, Departments of Pediatrics and Medicine(Dermatology), University of California, San Diego, School of MedicineAssociate Clinical Professor, Departments of Pediatrics and Medicine(Dermatology), University of California, San Diego, School of MedicineChief, Pediatric and Adolescent DermatologyRady Children's Hospital, San Diego, CAChief, Division of Dermatology, Department of Pediatrics, University ofCalifornia, San Diego, School of MedicineAssistant Clinical Professor, Departments of Pediatrics and Medicine(Dermatology), University of California, San Diego, School of MedicineLecturer, University of PennsylvaniaSchool of Nursing Primary Care Graduate ProgramAssistant Instructor in Dermatology, Department of Dermatology,University of Pennsylvania School of MedicineInstructor in Pediatrics, Department of Pediatrics, University ofPennsylvania School of MedicineAssistant Instructor in Pediatrics, Department of Pediatrics, Universityof Pennsylvania School of Medicine2009 – present2005 – present2001 – 20051997 – 20011991 – present1991 – present1991 – 19971990 – 19911988 – 19911987 – 19881984 – 1987HOSPITAL, UNIVERSITY AND ADMINISTRATIVE APPOINTMENTS/SERVICEUniversity of California San Diego NIH T32 Dermatology Training GrantAdvisory CommitteeUniversity of California San Diego Academy of Clinical ScholarsRecruitment Committee, Department of Pediatrics Clinical ResearchDirectorRady Children‘s Hospital/UCSD Scientific Operations CommitteeBoard of Governance, Rady Children‘s Specialists FoundationClinical & Translational Research Institute of the University ofCalifornia, San Diego, Community Advisory Board2012 – present2011 – present2011 – present2010 – present2009 – present2009 – 2012Page 3 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.Research Operations Committee, Rady Children‘s Hospital/University ofCalifornia, San Diego Department of PediatricsRady Children's Hospital/University of California, San Diego, GrantAllocation & Review CouncilRady Children‘s Hospital/UCSD/CSSD Medical Foundation ResearchCommitteeRecruitment Committee, Director of Pediatric Clinical Research,University of California, San Diego and Rady Children's Hospital, SanDiegoChair, Recruitment Committee, Dermatopathology, University ofCalifornia, San Diego, Division of Dermatology2009 – present2008 – present2008 – present2008 – present2008 – 2009Rady Children's Hospital Research Operating Committee 2008 – 2009Course Director –University of California, San Diego Med 280 Elective(dermBRIDGE)2008Director of Research, Children's Specialists, San Diego 2007 – 2009Co-Director, The Eczema Center, Rady Children's Hospital, San DiegoRecruitment Committee, Division Chiefs, Divisions of Pediatrics,Developmental Pediatrics, Adolescent Medicine and CommunityPediatricsCharter Member, Clinical and Translational Research Institute, Universityof California, San Diego2007 – present2007 – 20092005 – presentInformation Systems Planning Committee 2005 – 2008Integrated Delivery System-Information Technology Steering Committee 2005 – 2008Physician-in-Chief/Chairman of Pediatrics Recruitment Committee,UCSD/Rady Children's Hospital, San DiegoChair, Clinical Research Advisory Committee, Rady Children's Hospital,San DiegoChair, Cardiology Division Director Recruitment Committee,UCSD/Rady Children's Hospital/Children's Specialists, San DiegoResearch Issues GroupUCSD/Rady Children's Hospital and Health Center, San DiegoPhysician Advisory CommitteeRady Children's Hospital, San DiegoSteering CommitteeUCSD Department of Pediatrics/Children's Specialists of San Diego20042004 – 20082003 – 20052003 – 20052002 – 20052002 – 2005Page 4 of 69

Curriculum VitaeAugust 2012Graduate Education Committee (1984-1988)Residency Selection Committee (1986-1988)Executive Council of Medical Staff (1987-1988)Undergraduate Education Committee (1987-1988)Quality Assurance Committee (1987-1988)Resuscitation/Transport Committee (1987-1988)Children's Hospital of PhiladelphiaStudent Editor, Mount Sinai Journal of Medicine (1981-1982)Curriculum Committee (1981-1983)Admissions Committee (1983-1984)Mount Sinai School of Medicine, New York, NYLawrence F. Eichenfield, M.D.1984 – 19881981 – 1984NATIONAL ORGANIZATIONS: APPOINTMENTSAmerican Academy of Dermatology Association: DermatologyWorkgroup, Best Pharmaceuticals for Children Act (National Institutes ofHealth)2012American Academy of Dermatology: Named Lectureship Task Force 2012 - 2016American Academy of Dermatology: Council on Education 2010 – 2011Chair, 69 th Annual Meeting, American Academy of Dermatology February, 2011American Academy of Dermatology: Chair, Scientific AssemblyCommittee2010 – 2011American Academy of Dermatology: Organizational Structure Task Force 2010-2014National Institute of Allergy and Infectious Disease, Food Allergy ClinicalGuidelines: Coordinating CommitteeNational Institute of Allergy and Infectious Disease, Food Allergy ClinicalGuidelines: Expert Panel2008 – 20102008 – 2010Society for Pediatric Dermatology: Long Range Planning Committee 2009-2010Maui Healthcare Consensus Conference on Atopic Dermatitis: Chair 2008-9Maui Healthcare Consensus Conference on Acne Vulgaris: Member 2008-9National Psoriasis Foundation: Medical Board 2008 – 2011Food and Drug Administration (FDA): Dermatologic & OphthalmicDrugs Advisory Committee Meeting on Etanercept; Speaker, June 18"Update on Eczema, Atopic Conditions, and Inflammatory SkinDisorders," July 25-26; Co-Chair, in conjunction with the NationalEczema Association's 5 th Annual Meeting and Eczema Patient ConferenceSkin Disease Education Foundation: Member, Organizing Committee200820082007 – presentPage 6 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.American Academy of Dermatology: Chair, Quality Work Group, Issuesin Dermatology ConferenceAmerican Acne and Rosacea Society: Founding Board Member; Chair,Nominating CommitteeNational Eczema Association for Science and Education (NEASE):Scientific Advisory Committee (SAC)American Academy of Dermatology: Skin Cancer Reduction: InterventionPlan for Tomorrow (S.C.R.I.P.T.) Task Force20072006-20102006 – present2006 – 2009Sturge-Weber Foundation: Grant Review Committee 2006 – 2007Advances in Cosmetic and Medical Dermatology Meeting; ScientificAdvisory BoardAmerican Academy of Dermatology: The Leadership Circle forVolunteerism20072006 – 2008American Academy of Dermatology: Scientific Assembly Committee 2005 – 2011American Academy of Dermatology: Board of Directors, (Elected May,2004)American Academy of Dermatology:Needs Assessment Task ForceWorld Congress Fund Review Task Force2005 – 20092004 – 2008American Academy of Dermatology: Youth Education Committee 2004 – 2006American Academy of Dermatology: Board of Directors' Liaison to theSociety for Pediatric Dermatology2004 – 2006Board of Trustees, Dermatology Foundation 2003 – 2006Dermatology Foundation: Chair, Leaders Society, California – San Diego 2003 – 2006Society for Pediatric Dermatology: Meetings Committee 2003 – 2006American Academy of Dermatology: Work Group for the EczemaNetWebsite2003 – 2005President, Society for Pediatric Dermatology 2002 – 2003American Academy of Dermatology: Intersociety Liaison Committee 2002 – 2004American Academy of Dermatology: Ad Hoc Task Force to StudyCooperative Education with External OrganizationsAmerican Academy of Dermatology: Distance Learning & EnduringMaterials Committee; Co-Chair, Interdisciplinary and PostgraduateEducation Task Force2002 – 20032002 – 2003Page 7 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.American Board of Dermatology: Certification Exam Committee 2001 – 2005President-Elect, Society for Pediatric Dermatology 2001 – 2002American Board of Dermatology: Committee on Pediatric DermatologyCertificationAmerican Academy of Dermatology: San Diego Padres Skin CancerScreening Program (Director: 2001-2007; 2009)American Academy of Dermatology: Chairman, Consensus Conferenceon Pediatric Atopic DermatitisAmerican Academy of Dermatology: Task Force on Awards inExcellence; Council on EducationAmerican Academy of Dermatology: Chairman, InterdisciplinaryEducation & Postgraduate Education Task Force; Education Committee;Pediatric Dermatology for the 21 st CenturyEditor/Director, Internet Web Page (www.pedsderm.net), Society forPediatric Dermatology (Initiated site)Board of Directors, Society for Pediatric Dermatology; PublicationsCommittee2001 – 20042000 – present2000 – 20032000 – 20051998 – 20031997 – 20061997 – 2005Chairman, Membership Committee, Society for Pediatric Dermatology 1995 – 1997American Board of Dermatology: Test Committee for Recertification –Pediatric Dermatology SectionNational Institutes of Health Special Study Section onTechnology/Medical Lasers1994 – 20021993 – 1997Membership Committee, Society for Pediatric Dermatology 1992 – 1996Executive Board, Children's Hospital of Philadelphia Alumni Organization 1990 – 1991Secretary-Treasurer, Children's Hospital of Philadelphia AlumniOrganization1988 – 1990Consultant, National Board of Medical Examiners 1986 – 1987SOCIETIES/ORGANIZATIONS (INITIATING YEAR LISTED)Founding Member, American Acne and Rosacea Society 2006Scientific Advisory Board - Advances in Cosmetic & MedicalDermatology, Hawaii2006Society for Investigative Dermatology 2005Senior Member, International Society for the Study of Vascular Anomalies 2002Page 8 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.American Dermatology Association 2000Women's Dermatologic Society 1999American College of Physician Executives 1999Fellow, American Society of Laser Medicine and Surgery 1994Fellow, American Society of Dermatologic Surgery 1994Pediatric Dermatology Section, American Academy of Pediatrics 1993Fellow, American Academy of Dermatology 1991Society for Pediatric Dermatology 1988Fellow, American Academy of Pediatrics 1986Alpha Omega Alpha 1983EDITORIAL POSITIONSSenior Editor, Neonatal and Infant Dermatology, 3 rd Edition. EichenfieldLF, Frieden IJ, eds. Saunders/Elsevier, Philadelphia. 2013Editor in Chief, Pediatric Dermatology20122006 – presentAssociate Editor, Pediatric Dermatology 2004 – 2006Senior Editor, Neonatal Dermatology, 2 nd Edition. Eichenfield LF, FriedenIJ, Esterly NB, eds. Saunders/Elsevier, PhiladelphiaSenior Editor, Textbook of Neonatal Dermatology. Eichenfield LF,Frieden IJ, Esterly NB, eds. WB Saunders Company, Philadelphia2007-20082000-2001EDITORIAL BOARD/EDITORIAL ADVISORY POSITIONSClinical Investigation (Editorial Advisor, Dermatology)Treatment Strategies – DermatologyPsoriasis ForumJournal of Aesthetic and Clinical DermatologytheDerm.org (www.thederm.org)Parents MagazinePractical DermatologyContemporary Dermatology2010 - present2010 - present2010 – present2008 – present2008 – present2006 – present2004 – present2002 – presentPage 9 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.Journal of Drugs in Dermatology (Associate Editor, International EditorialBoard)Pediatric Dermatology2003 – present2002 – presentCurrent Opinion in Pediatrics 2001 – 2009Infectious Diseases in Children2001 – presentGUEST EDITORSHIPGuest Editor, Journal of Drugs in Dermatology 2012Guest Editor, theDerm.org (www.thederm.org) 2008Chair, Dermatology Insights Work Group 2003 – 2004Editor, "New Macrolides: Tacrolimus and Ascomycin." CutaneousSeminars in Medicine and Surgery2001Current Problems in Pediatrics (Pediatric Dermatology Volume) 1998REVIEWER/EXTERNAL CONTENT REFEREEJournal of Allergy and Clinical ImmunologyNew England Journal of MedicineCochrane Skin GroupJournal of American Medical Association (JAMA)Journal of Investigative DermatologyArchives of DermatologyJournal of the American Academy of DermatologyJournal of Dermatologic Surgery and OncologyPediatricsPediatric DermatologyJournal of Pediatrics2007 – present2006 – present2006 – present2006 – present2003 – present1997 – present1994 – present1994 – present1994 – present1991 – present1988 – presentRheumatology 2005 – 2007American Journal of Preventive Medicine2002 – presentSouthern Medical Journal 1996 – 1998Page 10 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.Pediatric Emergency Care 1999 – 2002Prenatal Diagnosis 1992 – 2005AHFS Drug Information Reviewer 1998 – 2000COLLABORATOR"Red Book: Report of the Committee on Infectious Diseases; AmericanAcademy of Pediatrics."2000; 2003, 2006;2009HONORS AND AWARDSPresidential Citation, American Academy of Dermatology - AADRepresentative for National Institute of Allergy and Infectious Disease,Food Allergy Clinical Guidelines: Coordinating Committee and ExpertPanel2012Top Doctor, US News & World Report 2011Physician of Exceptional Excellence / ―Top Doctor‖ – DermatologySan Diego County Medical Society2008 British Medical Association (BMA) Medical Book CompetitionAward: First Prize, Dermatology. Neonatal Dermatology, 2 nd Edition.Eichenfield LF, Frieden IJ, Easterly NB and Elsevier Ltd.2011, 2010, 2009,2008, 2007, 2006,2005, 2004, 2003,20022008Presidential Citation, American Academy of Dermatology 2007Gold Leadership Circle Award for Volunteerism, American Academy ofDermatologyAmerica's Top Doctors/The Best Doctors In AmericaCastle Connolly Medical, Ltd.America‘s Top Cosmetic Doctors and DentistsCastle Connolly Medical, Ltd.Robert W. Goltz Excellence in Teaching AwardUCSD Division of DermatologyContinuing Medical Education AwardRady Children's Hospital, San Diego20072011, 2010, 2009,2008, 2007, 2006,2005, 2004, 2003,2002, 1998-2001,1994-19962005, 200820042004Page 11 of 69

Curriculum VitaeAugust 2012Physician Leadership AwardRady Children's Hospital, San DiegoOutstanding Faculty Teaching AwardUCSD Department of PediatricsResident Forum AwardPennsylvania Academy of DermatologyBenjamin Ritter AwardChildren's Hospital of PhiladelphiaResident Honor Roll for Excellence in TeachingUniversity of Pennsylvania School of MedicineFelt Memorial Prize for Highest Overall PerformanceMount Sinai School of MedicineAlpha Omega AlphaMount Sinai School of MedicineLawrence F. Eichenfield, M.D.2001199219901988198519841983AMA-Education Research Foundation Scholarship in Clinical Nutrition;for study at Children's Hospital Medical Center, BostonNIH Fellowship for Summer Study, Divisions of PediatricGastroenterology and NephrologyMount Sinai School of Medicine, New York, NYJohn Woodruff Simpson Fellow for the Study of Medicine(Awarded by Amherst College)Bancroft Speaking PrizeAmherst CollegeGraduation Day Class SpeakerAmherst College198319821980-198119801980PUBLICATIONS1. Bindman AB, Eichenfield LF. Diagnosis related groups: physician and abstractor reliability andfinancial significance of errors. Mount Sinai Journal of Medicine. 1984; 51:237-245.2. Eichenfield LF, Bindman AB. Differences between faculty and community services in auniversity hospital. New England Journal of Medicine. 1984; 311:737 (Letter).3. Eichenfield LF, Johnston RB, Jr. Secondary disorders of the complement system. AmericanJournal of Diseases of Children 1989 May; 143:595-602. Reprinted as: Anomalies secondairesdu systeme complementaire. Pediatrie. 1989; 8:329-341.4. Eichenfield LF, Johnston RB, Jr. Low serum complement in anorexia nervosa. AmericanJournal of Diseases of Children. 1989; 143:1201-2 (Letter).Page 12 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.5. Eichenfield LF, Honig PJ, Nelson L. Traumatic granuloma of the tongue (riga-fede disease):association with familial dysautonomia. Journal of Pediatrics. 1990; 116:742-744.6. Eichenfield LF, Honig PJ. Difficult diagnostic and management problems in pediatricdermatology. Pediatric Clinics of North America. 1991 June; 38:687-710.7. Eichenfield LF, Honig PJ. Blistering disorders in childhood. Pediatric Clinics North America1991 Aug; 38:959-976.8. Eichenfield LF, Honig PJ. New developments in pediatric dermatology. Current Problems inPediatrics 1991; 21:421-426.9. Eichenfield LF, Leyden JJ. Acne: current concept of pathogenesis and rational basis fortherapy. Pediatrician 1991; 18:218-223.10. Barr FG, Davis RJ, Eichenfield LF, Emanuel BS. Structural analysis of a carcinogen-inducedgenomic rearrangement event. Proceedings National Academy of Science 1992; 89:942-946.11. Goskowicz M, Eichenfield LF. Cutaneous findings of nutritional deficiencies in children.Opinion in Pediatrics 1993; 5:441-445.12. Lemire JM, Joly JL, Griswold WR, Reznik VM, Eichenfield LF, Mendoza SA. Clinical quiz.Tuberous sclerosis (Bourneville's disease). Pediatric Nephrology 1994; 8(1):127-128.13. Wright WK, Krous HF, Griswold WR, Billman GF, Eichenfield LF, Lemire JM, Reznik VM.Pulmonary vasculitis with hemorrhage in anaphylactoid purpura. Pediatric Pulmonology 1994;17:269-271.14. Goskowicz M, Fallon-Friedlander SF, Eichenfield LF. Endemic "Lime" Disease:phytophotodermatitis in San Diego County. Pediatrics 1994; 93:828-830.15. Lucky A, Eichenfield LF, Hartley AH, Rasmussen JE. Proceeding of the 17 th annual meeting ofthe Society for Pediatric Dermatology. July 29-31, 1993, Snowmass, Colorado. PediatricDermatology 1994; 11:187-195.16. Costa T, Eichenfield LF, Krafchik BR. Costello syndrome. Pediatric Dermatology 1994;11:277-279.17. Goskowicz M, Eichenfield LF. Onychodystrophy with lichen striatus. Pediatric Dermatology1994; 11:282-283 (letter).18. Bird LM, Krous HF, Eichenfield LF, Stalwell CI, Jones MC. A female infant with histiocytoidcardiomyopathy of infancy (HCI) and microphthalmia with linear skin defects (MLS): a clue toetiology of HCI? American Journal of Medical Genetics 1994; 53:141-148.19. Thornton CM, Eichenfield LF, Shinall EA, Siegfried E, Rabinowitz LG, Esterly NB, LuckyAW, Friedlander SF. Cutaneous telangiectases in neonatal lupus erythematosus. Journal of theAmerican Academy of Dermatology 1995 Jul; 33:19-25.20. Mattheson BK, Gilbertson EO, Eichenfield LF. Vesiculopustular eruption of Crohn's disease.Pediatric Dermatology 1996; 13:127-130.21. Peterson CM, Eichenfield LF. Scabies. Pediatric Annals 1996; 25:97-100.Page 13 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.22. Weilepp AE, Eichenfield, LF. Association of glaucoma with cutis marmorata telangiectaticacongenita: a localized anatomic malformation. Journal of the American Academy ofDermatology 1996; 35:276-278.23. Friedlander SF, West A, Eichenfield LF. Isolated leukemia cutis presenting as "seborrheicdermatitis." Clinical Pediatrics (Philadelphia) 1996 Oct; 35 (10):531-534.24. Thornton CM, Eichenfield LF. Treatment of common cutaneous vascular disorders ofchildhood. Dermatologic Therapy 1996; 2:68-77.25. Fallon-Friedlander S, West A, Eichenfield LF. Aleukemic leukemia cutis. Clinical Pediatrics1996; 531-534.26. Eichenfield LF, Weilepp AE. Pain control in pediatric procedures. Current Opinions inDermatology. 1997; 4:157-161.27. Shaw D, Fine JD, Piacquadio DJ, Wang-Rodriguez J, Greenberg M, Eichenfield LF. Gastricoutlet obstruction and epidermolysis bullosa. Journal of the American Academy ofDermatology 1997 Feb; 36(2 pt 2):304-310.28. Christiano AM, Amano S, Eichenfield LF, Burgeson RE, Uitto J. Premature termination codonmutations in the type VII collagen gene in recessive dystrophic epidermolysis bullosa result innonsense-mediated mRNA decay and absence of functional protein. Journal of InvestigativeDermatology 1997 Sep; 109(3):390-394.29. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB. Guidelines of care forhemangiomas of infancy. American Academy of Dermatology Guidelines/OutcomesCommittee. Journal of the American Academy of Dermatology 1997 Oct; 37:631-637.30. Eichenfield LF, Levy ML, Paller AS, Riccardi VM. Guidelines of care for neurofibromatosistype 1. American Academy of Dermatology Guidelines/Outcomes Committee. Journal of theAmerican Academy of Dermatology 1997; 37:625-630.31. Colon-Fontanez F, Eichenfield LF. Treatment of head lice. Pediatric Infectious Disease Journal1998; 17:419-420.32. Eichenfield LF, Wright WK. Pulmonary hemorrhage associated with henoch-schonleinpurpura. Pediatric Dermatology 1998; 15:143.33. Colon-Fontanez F, Eichenfield LF, Krous HF, Friedlander SF. Congenital self-healinglangerhans cell histiocytosis: the possible use of the tzanck smear as a diagnostic screening test.Arch Dermatology 1998; 134:1039-1040.34. Eichenfield LF, Fallon Friedlander S. Coping with chronic dermatitis. Contemporary Pediatrics1998 Oct; 15(10):53-80.35. Eichenfield LF. Evolving knowledge of hemangiomas and vascular malformations: beyondstrawberries and port wine. Arch Dermatology 1998; 134(6):740-742.36. Cunningham B, Eichenfield LF. Pediatric dermatologic procedures: pain control. CurrentProblems in Dermatology 1999; 11:1-34.37. Sajben FP, Eichenfield LF, O'Grady TC, Cunningham BB. Cranial fasciitis of childhood.Pediatric Dermatology. 1999; 16:232-234.Page 14 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.38. Friedlander SF, Pickering B, Cunningham BB, Gibbs NF, Eichenfield LF. Use of the cottonswab method in diagnosing tinea capitis. Pediatrics 1999; 104:276-279.39. Eichenfield LF. Vascular lesion laser: practical techniques or some "light" suggestions.Pediatric Dermatology. 1999; 16:332-334.40. Giam YC, Williams ML, LeBoit PE, Orlow SJ, Eichenfield LF, Frieden IJ. Neonatal erosionsand ulcerations in giant congenital melanocytic nevi. Pediatric Dermatology. 1999; 16:354-358.41. Eichenfield LF, Hardaway CA. Neonatal Dermatology. Current Opinions in Pediatrics 1999Oct; 11(5):471-474.42. Eichenfield LF. Dermatology. Current Opinions in Pediatrics 1999 Oct; 11(5):445-446.43. Mendenhall AK, Eichenfield LF. Back to basics: caring for the newborn's skin. ContemporaryPediatrics. August 2000; 17(8):98-113.44. Chen B. Eichenfield LF. Advances in pediatric dermatologic surgery. Advances inDermatology. 2000; 16:477-501.45. Dohil M, Baugh W, Eichenfield LF. Pigmented and vascular birth marks. Pediatric Clinics ofNorth America. 2000 August; 47(4):783-812.46. Hoang MT, Eichenfield LF. The rising incidence of melanoma in children and adolescents.Dermatology Nursing 2000 June; 12(3):188-193.47. Eichenfield LF, Friedlander SF. Dermatology. Current Opinion in Pediatrics. 2000, 12:341.48. Talosig, MA, Mayer JA, Eckhardt L, Lewis EC, Kwon H, Belch GE, Eichenfield LF, Elder JP,Engelberg M. A national survey of sun safety activities at U.S. zoos. Journal of CommunityHealth. 2000; 24(4):331-342.49. Culley CA, Mayer JA, Eckhardt L, Busic AJ, Eichenfield LF, Sallis JF, Quintana PJ, WoodruffSI. Compliance with federal and state legislation by indoor tanning facilities in San Diego.Journal of the American Academy of Dermatology. 2001; 44(1):53-60.50. Paller A, Eichenfield LF, Leung DY, Steward D, Appell M. A 12-week study of tacrolimusointment for the treatment of atopic dermatitis in pediatric patients. Journal of the AmericanAcademy of Dermatology. 2001; 44:S47-57.51. Irrthum A, Brouillard P, Enjolras O, Gibbs NF, Eichenfield LF, Olsen BR, Mulliken JB, BoonLM, Vikkula M. Linkage disequilibrium narrows locus for venous malformation with glomuscells (VMGLOM) to a single 1.48 Mbp YAC. European Journal of Human Genetics. 2001 Jan;9(1):34-38.52. Lee D, Eichenfield LF. Atopic, contact and seborrheic dermatitis in adolescents. AdolescentMedicine: State of the Art Reviews. June 2001; 12(2):269-283.53. Boguniewicz M, Eichenfield L, Honig P. Pimecrolimus (Elidel, SDZ ASM 981) cream 1% issafe in the long-term management of atopic eczema. Journal of the European Academy ofDermatology and Venereology 2001; 15(Supplement 2):P2-12, 110.Page 15 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.54. Eichenfield LF, Hedgecock S, Marshall K. Pimecrolimus Cream 1% is safe and effective in thetreatment of pediatric atopic eczema. Journal of the European Academy of Dermatology andVenereology 2001; 15(Supplement 2): 95.55. Chen BK, Eichenfield LF. Pediatric anesthesia in dermatologic surgery: when hand-holding isnot enough. Dermatologic Surgery 2001 Dec; 27(12):1010-1018.56. Mayer JA, Lewis EC, Eckhardt L, Slymen D, Belch G, Elder J, Engelberg M, Eichenfield LF,Busic A, Nichols T, Walker K, Kwon H, Talosig M, Gearen C. Promoting sun safety amongzoo visitors. Preventive Medicine 2001 Sep; 33(3):162-169.57. Dohil MA, Eichenfield LF. Subcutaneous infusion anesthesia for dermatologic surgery inchildren: are we ready? Pediatric Dermatology 2001 Nov-Dec; 18(6):532-533.58. Eichenfield LF, Lucky AW, Boguniewicz M, Langley RG, Cherill R, Marshall K, Bush C,Graeber M. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mildand moderate atopic dermatitis in children and adolescents. Journal of the American Academyof Dermatology 2002 Apr; 46(4):495-504.59. Eichenfield LF, Funk A, Friedlander SF, Cunningham BB. A clinical study to evaluate theefficacy of ela-max (4% liposomal lidocaine) as compared with eutectic mixture of localanesthetics cream for pain reduction of venipuncture in children. Pediatrics. 2002 Jun;109(6):1093-1099.60. Bergman JN, Eichenfield LF. Neonatal acne and cephalic pustulosis: is malassezia the wholestory? Archives of Dermatology 2002 Feb; 138(2):255-257.61. Fleischer AB Jr, Ling M, Eichenfield LF, Satoi Y, Jaracz E, Rico MJ, Maher RM. Tacrolimusointment for the treatment of atopic dermatitis is not associated with an increase in cutaneousinfections. Journal of the American Academy of Dermatology 2002 Oct; 47(4):562-570.62. Bernard LA, Eichenfield LF. Topical immunomodulators for atopic dermatitis. CurrentOpinions in Pediatrics 2002; 14:414-418.63. Bernard LA, Cunningham BB, Al-Suwaidan S, Friedlander SF, Eichenfield LF. A rosacea-likegranulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis. Archivesof Dermatology 2003 Feb; 139(2):229-231.64. Paller AS, Nimmagadda S, Schachner L, Mallory SB, Kahn T, Willis I, Eichenfield LF.Fluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even inpatients who are peanut sensitive. Journal of the American Academy of Dermatology 2003 Apr;48(4):569-577.65. Richard G, Brown N, Rouan F, Van der Schroeff JG, Bijlsma E, Eichenfield LF, Sybert VP,Greer KE, Hogan P, Campanelli C, Compton JG, Bale SJ, DiGiovanna JJ, Uitto J. Geneticheterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4(Cx30.3) and genotype-phenotype correlations. J Invest Dermatol 2003 Apr; 120(4):601-609.66. Colon-Fontanez F, Eichenfield LF, Friedlander SF, Newberry R. Bullous aplasia cutiscongenita: report of a case and literature review. J Am Acad Dermatol 2003 May; 48(5Suppl):S95-98.Page 16 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.67. Eichenfield LF, Beck L. Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for thetreatment of atopic dermatitis. J Allergy Clin Immunol 2003 May; 111(5):1153-1168.68. Eichenfield LF, Hanifin JM, Beck LA, Lemanske RF Jr, Sampson HA, Weiss ST, Leung DY.Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics 2003 Mar;111(3):608-616.69. Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, Eichenfield LF, FerrandizC, Giannetti A, Hanifin J, Koo JY, Leung D, Lynde C, Ring J, Ruiz-Maldonado R, Saurat JH.International consensus conference on atopic dermatitis II (ICCAD II): clinical update andcurrent treatment strategies. Br J Dermatol 2003 May: 148 Suppl 63:3-10.70. Dohil MA, Billman G, Pransky S, Eichenfield LF. The congenital lingual melanotic macule.Arch Dermatol 2003 Jun; 139(6):767-770.71. Shainhouse T, Eichenfield LF. Long-term safety of tacrolimus ointment in children treated foratopic dermatitis. Expert Opin Drug Saf 2003 Sep; 2(5):457-465.72. Eichenfield LF, AW, Boguniewicz M, Langley RG, Cherill R, Marshall K. 1% pimecrolimuscream for atopic dermatitis. Archives of Dermatology 2003 Oct; 139(10):1369-1970; authorreply 1370-1371.73. Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference onpediatric atopic dermatitis. J Am Acad Dermatol 2003 Dec; 49(6):1088-95.74. Boguniewicz M, Eichenfield LF, Hultsch T. Current management of atopic dermatitis andinterruption of the atopic march. J Allergy Clin Immunol 2003 Dec; 112(6 Suppl):S140-150.Review.75. Ritter MR, Moreno SK, Dorrell MI, Rubens J, Ney J, Friedlander DF, Bergman J, CunninghamBB, Eichenfield LF, Reinisch J, Cohen S, Veccione T, Holmes R, Friedlander SF, FriedlanderM. Identifying potential regulators of infantile hemangioma progression through large-scaleexpression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase(IDO) during involution. Lymphatic Research and Biology 2003; 1(4):291-299.76. Barbier N, Paul C, Luger T, Allen R, De Prost Y, Papp K, Eichenfield LF, Cherill R, Hanifin J.Validation of the eczema area and severity index for atopic dermatitis in a cohort of 1550patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.British Journal of Dermatology 2004 Jan; 150(1):96-102.77. Satter EK, Maari CH, Morel KD, Eichenfield LF, Cunningham BB, Friedlander SF, Bergman JN.Disseminated linear calcinosis cutis associated with the Koebner phenomenon in an infant withcongenital acute monocytic leukaemia. British Journal of Dermatology 2004 Apr; 150(4):753-756.78. Nahm WK, Moise S, Eichenfield LF, Paller AS, Nathanson L, Malicki DM, Friedlander SF.Vascular malformations in blue rubber bleb nevus syndrome: variable onset of presentation.Journal of American Academy of Dermatology 2004 May; 50(5 Suppl):S101-106. Review.79. Shaw DW, Eichenfield LF, Shainhouse T, Maibach HI. Allergic contact dermatitis fromtacrolimus. Journal of American Academy of Dermatology 2004 Jun; 50(6):962-965.Page 17 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.80. Staab D, Pariser D, Gottlieb A, Kaufmann R, Eichenfield LF, Langley RG, Scott G, Ebelin ME,Barilla D, Schmidli H, Burtin P. Low system absorption and good tolerability of pimecrolimus,administered as 1% cream (Elidel®) in infants with atopic dermatitis – a multicenter, 3-week,open-label study. Pediatric Dermatology. 2005 Sep-Oct;22(5):465-471.81. Eichenfield LF, Lucky AW, Langley RG, Lynde C, Kaufmann R, Todd G, Lindsley L, BarbierN, Felser JM. Use of pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis ininfants and children: the effects of ethnic origin and baseline disease severity on treatmentoutcome. International Journal of Dermatology 2005 Jan; 44(1):70-7582. Oh SS, Mayer JA, Lewis EC, Slymen DJ, Sallis JF, Elder JP, Eckhardt L, Achter A, WeinstockM, Eichenfield LF, Pichon LC, Galindo GR. Validating outdoor workers' self-report of sunprotection. Preventive Medicine 2004 Oct; 39(4):798-803.83. Cunningham BB, Gigler V, Wang K, Eichenfield LF, Friedlander SF, Garden JM, McFarlaneS, Faierman A, Wagner A. General Anesthesia for pediatric dermatologic procedures: risks andcomplications. Archives of Dermatology 2005 May; 141(5):573-576.84. Eichenfield LF, Dohil M, Paller A, Lucky A. Molluscum contagiosum in children-who getsthem? Journal of the American Academy of Dermatology 2004 Mar; 50(3):134-134.85. DiGiovanna JJ, Langman CB, Tschen EH, Jones T, Menter A, Lowe NJ, Eichenfield LF,Hebert AA, Pariser D, Savin RP, Smith SR, Jarratt M, Rodriguez D, Chalker DK, Kempers S,Ling M, Rafal ES, Sullivan S, Kang S, Shah LP, Wu E, Newhouse J, Pak J, Eberhardt DR,Bryce GF, McLane JA, Ondovik M, Chin C, Khoo KC, Rich P. Effect of a single course ofisotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant,nodular acne. Journal of American Academy of Dermatology 2004 Nov; 51(5):709-17.86. Eichenfield LF, Carney PS, Chow MJ, Tal A, Weinberg JM, Yurko M. Unique approaches forthe topical treatment and prevention of cutaneous infections; report from a clinical roundtable.Cutis 2004 Aug; 74(2 Suppl):2-23.87. Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy2004 Aug;59 Suppl 78:86-92.88. Buka RL, Eichenfield LF. Neonatal dermatology – a primer for the clinician. Cont Derm 2004;2:1-6.89. Roberts BJ, Eichenfield LF. Atopic Eczema. Editorial. Drugs in Context, Part E: RespiratoryMedicine and Infections. 2004; 1(10): 358-359.90. Williams JV, Eichenfield LF, Burke BL, Barnes-Ely M, Friedlander SF. Prevalence of scalpscaling in prepubertal children. Pediatrics 2005 Jan; 115(1):e1-e6.91. Dohil MA, Eichenfield LF. A treatment approach for atopic dermatitis. Pediatric Annals 2005Mar; 34(3):201-210.92. Barnes CJ, Eichenfield LF, Lee J, Cunningham BB. A practical approach for the use of oralisotretinoin for infantile acne. Pediatric Dermatology 2005; 22(2):166-169.Page 18 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.93. Hanifin J, Paller AS, Eichenfield LF, Clark RA, Korman N, Weinstein G, Caro I, Jaracz E,Rico MJ; US Tacrolimus Ointment Study Group. Efficacy and safety of tacrolimus ointmenttreatment for up to 4 years in patients with atopic dermatitis. Journal of the American Academyof Dermatology 2005;53(2):S186-S194.94. Huiras EE, Barnes CJ, Eichenfield LF, Pelech AN, Drolet BA. Pulmonary thromboembolismassociated with Klippel-Trenaunay Syndrome. Pediatrics 2005 Oct;116(4):596-600.95. Eichenfield LF, Fried RG, Taylor SC, Paller AS, Theos A. Acne and your pediatric patient: aroundtable discussion of treatment modalities and other factors. Cutis. 2005 Nov; 76(5Suppl):5-24.96. Dohil M, Eichenfield LF. Atopic dermatitis – treatment update. California Pediatrician Spring2005; 21 (1):18-19.97. Eichenfield LF. New developments in pediatric dermatology. Supplement to Skin and Aging2005; February: 19-20.98. Eichenfield LF. Advances in topical Immunomodulators. Supplement to Skin and Aging 2005;February:21-22.99. Chan YC, Eichenfield LF, Malchiodi J, Friedlander SF. Small facial Haemangioma andsupraumbilical raphe—a forme fruste of PHACES syndrome? British Journal of Dermatology.2005 Nov;153(5):1053-1057.100. Baumann LS, Eichenfield LF, Taylor SC. Advancing the science of naturals. CosmeticDermatology 2005; 18(12):2-8.101. Dohil MA, Lin P, Lee J, Lucky AW, Paller A, Eichenfield LF. The epidemiology ofMolluscum contagiosum in children. Journal of the American Academy of Dermatology 2006;54(1):47-54.102. Eichenfield LF, Miller AD. Evolving management of atopic dermatitis. Expert ReviewDermatology 2006; 1(1):31-41.102a Eichenfield LF, Miller BH. Two randomized, double-blind, placebo-controlled studies offluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from 3months of age. Journal of American Academy of Dermatology. 2006 Apr;54(4):715-7. (moveddue to categorized incorrectly previous version)103. Vearrier D, Buka RL, Roberts B, Cunningham BB, Eichenfield LF, Friedlander SF. What isstandard of care in the evaluation of elastosis perforans serpiginosa? A survey of pediatricdermatologists. Pediatric Dermatology. 2006 May-Jun;23(3):219-24104. Eichenfield LF, Ellis C, Fivenson D, Hebert A, Dromgoole S, Piacquadio D, . Systemic safetyof a lipid enhanced, emollient cream formulation of topical hydrocortisone butyrate 0.1% intreating children with atopic dermatitis. Pediatric Dermatology. 2005 (in press).105. Mayer JA, Slymen DJ, Clapp EJ, Pichon LC, Eckhardt L, Eichenfield LF. Promoting the sunsafety of United States Postal Service letter carriers. American Journal of Public Health2005(in press).Page 19 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.106. Chiang C, Eichenfield LF. Quantitative measurement of bathing and moisturizer inducedchanges in skin hydration in atopic dermatitis subjects. Journal of Academy of Dermatology.2006 (in press).107. Zulian F, Vallongo C, Knupp S, Punaro M, Ros J, Mazur-Zielinska H, Galea P, Da Dalt L,Eichenfield LF. Congenital localized scleroderma. Journal of Pediatrics 2006: 4:52-55.------------------------108. Nguyen V, Eichenfield LF. Periorificial dermatitis in children and adolescents. Journal of theAmerican Academy of Dermatology 2006 Nov;55(5):781-785.109. Shaw DW, Maibach HI, Eichenfield LF. Allergic contact dermatitis from pimecrolimus in apatient with tacrolimus allergy. Journal of the American Academy of Dermatology. 2007Feb;56(2):342-345.110. Izadpanah A, Hogeling M, Buka RL, Eichenfield LF, Bird LM. Digitocutaneous dysplasia.Journal of the American Academy of Dermatology. 2007 Feb;56(2 Suppl):S6-9.111. Marqueling AL, Gilliam AE, Prendiville J, Zvulunov A, Antaya RJ, Sugarman J, Pang ML, LeeP, Eichenfield L, Metz B, Goldberg G, Phillips RJ, Frieden IJ. Keratosis pilaris rubra, acommon but underrecognized condition. Archives of Dermatology. 2006 Dec;142:1611-1616.112. Callen J, Chamlin S, Eichenfield LF, Ellis C, Girardi M, Goldfarb M, Hanifin J, Lee P,Margolis D, Paller AS, Piacquadio D, Peterson W, Kaulback K, Fennerty M, Wintroub BU. Asystematic review of the safety of topical therapies for atopic dermatitis. British Journal ofDermatology 2007 Feb;156(2):203-221.113. Nguyen V, Buka RL, Roberts BJ, Eichenfield LF. Cutaneous Manifestations of Costellosyndrome. International Journal of Dermatology 2007 Jan;46(1):72-76.114. Krueger GG, Eichenfield L, Goodman JJ, Krafchik BR, Carlin CS, Pang ML , Croy R, HolumME, Jaracz E, Sawamoto T. Pharmacokinetics of tacrolimus following topical application oftacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis.Journal of Drugs in Dermatology. 2007 Feb;6(2):185-193.115. Yeo LF, Eichenfield LF, Chan YC. Skin surgery in children: local anesthesia and sedationtechniques. Expert Opinion in Pharmacotherapy. 2007 Feb;8(3):317-327.116. Eichenfield L, Ellis CN, Fivenson D, Hebert AA, Dromgoole S, Piacquadio D. Evaluation ofadrenal suppression of a lipid enhanced, topical emollient cream formulation of hydrocortisonebutyrate 0.1% in treating children with atopic dermatitis. Pediatric Dermatology 2007 Jan-Feb;24(1)81-4.117. Maari CH, Eichenfield LF. Congenital generalized hypomelanosis and immunodeficiency in ablack child. Pediatric Dermatology 2007 March/April;24(2) 182-185.118. Eichenfield LF, Ho V, Matsunaga J, Leclere P, Paul C, Hanifin JM. Blood concentrations,tolerability, and efficacy of pimecrolimus cream 1% in Japanese infants and children withatopic dermatitis. Journal of Dermatology 2007 Apr;34(4):231-236.119. Eichenfield LF, Bogen ML. Absorption and efficacy of miconazole nitrate 0.25% ointment ininfants with diaper dermatitis. Journal of Drugs in Dermatology 2007 May;6(5) 522-526.Page 20 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.120. Eichenfield LF, Basu S, Clavarese B, Trancik RJ. Effect of Desonide hydrogel 0.05% on thehypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopicdermatitis. Pediatric Dermatology 2007 May/June; 24(3) 289-295.121. Krakowski AC, Eichenfield LF. Pediatric acne: clinical presentations, evaluation, andmanagement. Journal of Drugs in Dermatology 2007 June;6(6) 589-593.122. Schlessinger J, Menter A, Gold M, Leonardi C, Eichenfield L, Plott RT, Leyden J, WortzmanM, ZIANA Study Group. Clinical safety and efficacy studies of a novel formulation combining1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. Journal ofDrugs in Dermatology. 2007 June;6(6):607-6015.123. Mayer JA, Slymen DJ; Clapp EJ; Pichon LC; Eckhardt L; Eichenfield LF; Elder JP, Sallis JF,Weinstock MA, Achter A, Balderrama C, Galindo GR, Oh SS. Promoting sun safety among USpostal service letter carriers: impact of a 2-year intervention. American Journal of Public Health2007 Aug;97(8):1350.124. Nguyen V, Cunningham BB, Eichenfield LF, Alio AB, Buka RL. Treatment of ichthyosiformdiseases with topically applied tazarotene: risk of systemic absorption. Journal of AmericanAcademy of Dermatology 2007 Nov; 57(5Suppl):S123-125.125. Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, Liu Y, Graeber M, Kang S,Adapalene-BPO Study Group. Adapalene-benzoyl peroxide, a fixed-dose combination for thetreatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.Journal of American Academy of Dermatology 2007 Nov; 57(5):791-799.126. Eichenfield LF, Fowler JF Jr, Rigel DS, Taylor SC. Natural advances in eczema care. Cutis2007 Dec;80 (6 Suppl):2-16.127. Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Hebert AA,Eichenfield LF, Patel V, Creamer K, Jahreis A. Etanercept treatment for children andadolescents with plaque psoriasis. New England Journal of Medicine 2008 Jan;358(3):241-251.128. Myhre PE, Levy ML, Eichenfield LF, Kolb VB, Fielder SL, Meng TC. Pharmacokinetics andsafety of imiquimod 5% cream in the treatment of molluscum contagiosum in children.Pediatric Dermatology. 2008 Jan-Feb;25(1):99-95.129. Langley RG, Eichenfield LF, Lucky AW, Boguniewicz M, Barbier N, Cherill R. Sustainedefficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treatchildren with atopic dermatitis. Pediatric Dermatology. 2008 May-Jun;25(3):301-307.130. Lam J, Dohil MA, Eichenfield LF, Cunningham BB. SCALP syndrome: sebaceous nevussyndrome, CNS malformations, aplasia cutis congenital, limbal dermoid, and pigmented nevus(giant congenital melanocytic nevus) with neurocutaneous melanosis: a distinct syndromicentity. Journal of American Academy of Dermatology. 2008 May; 58(5):884-888. E-pub 2008Jan 30.131. Boguniewicz M, Zeichner JA, Eichenfield LF, Hebert AA, Jarratt M, Lucky AW, Paller AS.MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants andchildren: a multicenter, randomized, vehicle-controlled study. Journal of Pediatrics 2008Jun;152(6):854-859.Page 21 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.132. Breneman D, Fleischer AB Jr, Abramovits W, Zeichner J, Gold MH, Kirsner RS, Shull TF,Crowe AW, Jaracz E, Hanifin JM: Tacrolimus ointment study group. Intermittent therapy forflare prevention and long-term disease control in stabilized atopic dermatitis: a randomizedcomparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. Journal ofAmerican Academy of Dermatology. 2008 Jun;58(6):990-999. Epub 2008 Mar21.133. Krakowski AC, Stendardo S, Eichenfield LF. Practical considerations in acne treatment and theclinical impact of topical combination therapy. Pediatric Dermatology 2008 Jun;25(Suppl 1):1-14.134. Jacob SE, Zapolanski T, Chayavichitsilp P, Connelly EA, Eichenfield LF. p-Phenylenediaminein black henna tattoos: a practice in need of policy in children. Archives of PediatricAdolescent Medicine. 2008 Aug;162(8):790-792.135. Krakowski AC, Eichenfield LF, Dohil MA. State-of-the-art review article: Management ofAtopic Dermatitis in the Pediatric Population. Pediatrics 2008 Oct;122(4):812-824.136. Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL, US tacrolimus ointmentstudy group. Three times weekly tacrolimus ointment reduces relapse in stabilized atopicdermatitis: a new paradigm for use. Pediatrics. 2008 Dec; 122(6): e1210-e1218. Epub 2008Nov 17.137. Yan AC, Frieden IJ, Eichenfield LF. Pediatric Dermatology. Announcing a new section.Pediatric Dermatology. 2008 Nov-Dec; 25(6):585-586.138. Eichenfield LF, Nighland M, Rossi AB, Cook-Bolden F, Grimes P, Fried R, Levy S, PUMPStudy Group. Phase 4 study to assess tretinoin pump for the treatment of facial acne. Journal ofDrugs in Dermatology. 2008 Dec; 7(12):1129-1136.139. Mayer JA, Slymen DJ, Clapp EJ, Pichon LC, Elder JP, Sallis JF, Eichenfield LF, WeinstockMA. Long-term maintenance of a successful occupational sun safety intervention. Archives ofDermatology. 2009 Jan;145(1):88-89.140. Chiang C, Eichenfield LF. Quantitative assessment of combination bathing and moisturizingregimens on skin hydration in atopic dermatitis. Pediatric Dermatology. 2009May/Jun;26(3):273-278.141. Eichenfield LF, Wortzman M. A novel gel formulation of 0.25% tretinoin and 1.2%clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years. PediatricDermatology. 2009 May/Jun;26(3):257-261.142. Dohil MA, Alvarez-Connelly E, Eichenfield LF. Fluocinolone acetonide 0.01% in peanut oil:safety and efficacy data in the treatment of childhood atopic dermatitis in infants as young as 3months of age. Pediatric Dermatology. 2009 May/Jun;26(3):262-268.------------------------143. Thiboutot D, Eichenfield L, Shalita A, Del Rosso JQ, Swinyer L, Tanghetti E, Tschen E, ParrL. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoylperoxide. Cutis. 2009 Jul;84(1):48-55.Page 22 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.144. Eichenfield L. Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5%gel: focus on acne patient benefits and clinical use: Introduction. Cutis. 2009 Nov;84(5Suppl):3-4.145. Eichenfield LF, Thiboutot D, Shalita A, Swinyer L, Tanghetti E, Tschen E, Parr L. A threestepacne system containing solubilized benzoyl peroxide versus benzoyl peroxide/clindamycinin pediatric patients with acne. Journal of Clinical Aesthetic Dermatology. 2009 Nov;2(11):21-26.146. Eichenfield LF, McCollum A, Msika P. The benefits of sunflower oleodistillate (SOD) inpediatric dermatology. Pediatric Dermatology. 2009 Nov;26(6):669-75.147. Eichenfield L. Improving treatment outcomes: tolerability of a fixed-combination clindamycin1%-benzoyl peroxide 5% hydrating gel as monotherapy or in combination with a retinoid.Cutis. 2009 Nov;84(5 Suppl):12-7.148. Fleischer AB, Shalita A, Eichenfield LF, Abramovits, Lucky A, Garrett S, Dapsone Gel StudyGroup. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4%, ormoisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.Journal of Drugs in Dermatology. 2010 Jan;9(1):33-40.149. Gold LS, Cruz A, Eichenfield L, Tan J, Jorizzo J, Kerrouche N, Dhuin JC. Effective and safecombination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blindstudy of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycyclinehyclate 100 mg. Cutis. 2010 Feb;85(2):94-104.150. Wright NA, Piggott CDS, Eichenfield LF. The role of biologics and other systemic agents inthe treatment of pediatric psoriasis. Seminars in Cutaneous Medicine and Surgery, Psoriasisand Biologics. 2010 Mar;29(1):20-27.151. Eichenfield LF, Matiz C, Funk A, Dill SW. Study of the efficacy and tolerability of 0.04%tretinoin microsphere gel for preadolescent acne. Pediatrics. 2010 Jun;125(6):e1316-e1323.Epub 2010 May 24.152. Fried RG, Webster GF, Eichenfield LF, Friedlander SF, Fowler JF Jr, Levy ML. Perspectiveson therapeutic options for acne: an update. Seminars in Cutaneous Medicine and Surgery. 2010Jun;29(2 Supp1):13-16. Review153. Meurer M, Eichenfield LF, Ho V, Potter PC, Werfel T, Hultsch T. Addition of pimecrolimuscream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopicdermatitis: a randomized, double-blind trial. Journal of Dermatological Treatment. 2010May;21(3):157-66.154. Eichenfield LF, Fowler JF Jr, Friedlander SF, Levy ML, Webster GF. Diagnosis and evaluationof acne. Seminars in Cutaneous Medicine and Surgery. 2010 Jun;29(2 Supplement 1):5-8.155. Fried RG, Webster GF, Eichenfield LF, Friedlander SF, Fowler JF Jr, Levy ML. Medical andpsychosocial impact of acne. Seminars in Cutaneous Medicine and Surgery. 2010Jun;29(2Suppl):9-12.Page 23 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.156. Eichenfield LF, Jarratt M, Schlessinger J, Kempers S, Manna V, Hwa J, Liu Y, Graeber M.Adapalene 0.1% Lotion in the treatment of acne vulgaris: results from two placebo-controlled,multicenter, randomized double-blind, clinical studies. Journal of Drugs in Dermatology. 2010Jun;9(6):639-646.157. Friedlander SF, Eichenfield LF, Fowler JF Jr, Fried RG, Levy ML, Webster GF. Acneepidemiology and pathophysiology. Seminars in Cutaneous Medicine and Surgery. 2010Jun;29(2 Supplement 1):2-4.158. Eichenfield LF, Fowler JF, Fried RG, Friedlander SF, Levy ML, Webster GF. Perspectives ontherapeutic options for acne: an update. Seminars in Cutaneous Medicine and Surgery. 2010Jun;29(2 Supplement 1):13-16.159. Eichenfield LF. Facing the challenge of acne. Introduction. Seminars in Cutaneous Medicineand Surgery. 2010 Jun;29(2 Supplement 1):1. Duplicate of 160.160. Eichenfield LF. Facing the challenge of acne vulgaris in pediatric patients. Introduction.Seminars in Cutaneous Medicine and Surgery. 2010 Jun;29(2 Supplement 1):1.161. Paller AS, Eichenfield LF, Langley RG, Leonardi CL, Siegfried EC, Creamer K, Kricorian G.Subgroup analyses of etanercept in pediatric patients with psoriasis. Journal of AmericanAcademy of Dermatology. 2010 Aug;63(2):e38-41.162. McCollum AD, Paik A, Eichenfield LF. The safety and efficacy of tacrolimus ointment inpediatric patients with atopic dermatitis. Pediatric Dermatology. 2010 Sep/Oct;27(5):425-436.163. Siegfried EC, Eichenfield LF, Paller AS, Pariser D, Creamer K, Kricorian G. Intermittentetanercept therapy in pediatric patients with psoriasis. Journal of American Academy ofDermatology. 2010 Nov;63(5):769-74. Epub 2010 Sep 15.164. Paller AS, Siegfried EC, Eichenfield LF, Pariser D, Langley RG, Creamer K, Kricorian G.Long-term etanercept in pediatric patients with plaque psoriasis. Journal of American Academyof Dermatology. 2010 Nov;63(5):762-768.165. Eichenfield LF, Jorizzo JL, Dirschka T, Taub AF, Lynde C, Graeber M, Kerrouche N.Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalenebenzoylperoxide combination topical gel: efficacy and safety. Journal of Drugs inDermatology. 2010 Nov;9(11):1395-1401.166. Newman E, Eichenfield LF. Granular cell tumor on the palm of an 8-year-old girl. PediatricDermatology. 2010 Nov/Dec;27(6):653-658.167. Eichenfield LF, Reyes Merin M. Best practices in: managing eczema with natural ingredients.Skin & Allergy News. 2010 Nov; 41(11) Supplement.168. Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF,Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, EichenfieldLF, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM,Schneider LC, Simon RA, Simons FER, Teach SJ, Yawn BP, Schwaninger JM. Guidelines forthe diagnosis and management of food allergy in the United States: Summary of the NIAIDsponsoredexpert panel report. Journal of Allergy and Clinical Immunology. 2010Dec;126(6):1105-1118.Page 24 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.169. NIAID-Sponsored Expert Panel, Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA,Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-BredbennerC, Camargo CA Jr, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD,Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, YawnBP, Schwaninger JM. Guidelines for the diagnosis and management of food allergy in theUnited States: report of the NIAID-sponsored expert panel. Journal of Allergy and ClinicalImmunology. 2010 Dec;126(6 Suppl):S1-58.170. Matiz C, Tom WL, Eichenfield LF, Pong A, Friedlander SF. Children with atopic dermatitisappear less likely to be infected with community acquired methicillin-resistant staphylococcusaureus: The San Diego experience. Pediatric Dermatology. 2011 Jan-Feb;28(1):6-11.171. Boyce JA, Assa‘ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF,Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA Jr,Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S,McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM.Guidelines for the diagnosis and management of food allergy in the United States: summary ofthe NIAID-sponsored expert panel report. Nutrition Research. 2011 Jan;31(1):61-75.172. Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF,Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA Jr, EichenfieldL, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM,Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM. Guidelines forthe diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report. Journal of the American Academy of Dermatology. 2011Jan;64(1):175-192.173. Boyce JA, Assa‘ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF,Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA Jr,Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S,McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM;NIAID-sponsored Expert Panel. Guidelines for the diagnosis and management of food allergyin the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition. 2011Feb;27(2):253-267.174. Tom WL, Hsu JW, Eichenfield LF, Friedlander SF. Pediatric ―STUMP‖ lesions: evaluation andmanagement of difficult atypical Spitzoid lesions in children. Journal of the AmericanAcademy of Dermatology. 2011 Mar;64(3):559-572. Epub 2011 Jan 20.175. Hook KP, Eichenfield LF. Approach to the neonate with ecchymoses and crusts. DermatologicTherapy. 2011 Mar/Apr;24(2):240-248.176. Jacob SE, Herro EM, Sullivan K, Matiz C, Eichenfield L, Hamann C. Safety and efficacyevaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescents. Dermatitis.2011 Aug:1;22(4):204-210.177. Hodgkiss-Harlow CJ, Eichenfield LF, Dohil MA. Effective monitoring of isotretinoin safety ina pediatric dermatology population: A novel ―patient symptom survey‖ approach. Journal ofAmerican Academy of Dermatology. 2011 Sep;65(3):517-24. Epub 2011 May 31.178. Fortina AB, Romano I, Pescerio A, Eichenfield LF. Contact sensitization in very youngchildren. Journal of American Academy of Dermatology. 2011 Oct;65(4):772-779. Epub 2011May 25.Page 25 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.179. Eichenfield LF. Pediatric Acne Management: Optimizing Outcomes. Introduction. Seminars inCutaneous Medicine and Surgery. 2011 Sep;30(3S):S1.180. Mancini AJ, Baldwin HE, Eichenfield LF, Fallon Friedlander S, Yan AC. Acne life cycle: thespectrum of pediatric disease. Seminars in Cutaneous Medicine and Surgery. 2011Sep;30(3S):S2-S5.181. Fallon Friedlander S, Baldwin HE, Mancini AJ, Yan AC, Eichenfield LF. The acne continuum:an age-based approach to therapy. Seminars in Cutaneous Medicine and Surgery. 2011Sep;30(3S):S6-S11.182. Baldwin HE, Fallon Friedlander S, Eichenfield LF, Mancini AJ, Yan AC. The effects ofculture, skin color, and other nonclinical issues on acne treatment. Seminars in CutaneousMedicine and Surgery. 2011 Sep;30(3S):S12-15.183. Yan AC, Baldwin HE, Eichenfield LF, Fallon Friedlander S, Mancini AJ. Approach to pediatricacne treatment: an update. Seminars in Cutaneous Medicine and Surgery. 2011Sep;30(3S):S16-21.184. Eichenfield LF, Mancini AJ, Yan AC, Fallon Friedlander S, Baldwin HE. Parents as partnersin pediatric acne management. Seminars in Cutaneous Medicine and Surgery. 2011Sep;30(3S):S22.185. Eichenfield LF, Alio Saenz AB. Safety and Efficacy of clindamycin phosphate 1.2%-benzoylperoxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3,multicenter, randomized, double-blind, active- and vehicle-controlled study. Journal of Drugsin Dermatology. 2011 Dec;10(12):1382-1396.186. Melancon JM, Dohil MA, Eichenfield LF. Facial port-wine stain: when to worry? PediatricDermatology. 2012 Jan; 29(1):131-133.187. Hsu S, Papp KA, Lebwohl MG, Bagel J, Blauvelt A, Duffin KC, Crowley J, Eichenfield LF,Feldman SR, Fiorentino DF, Gelfand JM, Gottlieb AB, Jacobsen C, Kalb RE, Kavanaugh A,Korman NJ, Krueger GG, Michelon MA, Morison W, Ritchlin CT, Stein Gold L, Stone SP,Strober BE, Van Voorhees AS, Weiss SC, Wanat K, Bebo BF Jr. Consensus guidelines for themanagement of plaque psoriasis. Archives of Dermatology. 2012 Jan:148(1):95-102.IN PRESSBOOKS, CHAPTERS, BOOK REVIEWS1. Honig PJ, Eichenfield, LF, Rabinowitz L. Dermatology. In: Ditmar MF and Polin RA, eds.Pediatric Secrets. Philadelphia: CV Mosby/Hanley; 1989.2. Honig PJ, Eichenfield LF, Rabinowitz L. Dermatology. In: Ditmar MF and Polin RA eds.Pediatric Secrets, 2 nd Edition. Philadelphia: CV Mosby/Hanley; 1996.3. Eichenfield LF. Food allergy: a practical approach to diagnosis and treatment. Chiaramonte LT,Schneider A, Lifshitz F, eds. Pediatric Dermatology. New York: Marcel Dekker; 1989; 6:257-258(book review).Page 26 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.4. Eichenfield LF. Acyclovir therapy for herpes virus infections. Baker DA, ed. PediatricDermatology. New York: Marcel Dekker. 1990; 7:239 (book review).5. Eichenfield LF, Johnston RB Jr. The complement system. In: Sigal L, ed. Basic and ClinicalImmunology: an Integrated Approach. New York: McGraw-Hill; 1993.6. Fallon Friedlander S, Eichenfield LF. Skin. In: Rudolph A, Kamei R, eds. Rudolph'sFundamentals of Pediatrics. New York: Appleton-Lange; 1994 (2 nd ed. 1998).7. Eichenfield LF. Disorders of pigmentation. In: Burg FD, Ingelfinger JR, Wald ER, Polin RA, eds.Current Pediatric Therapy. Philadelphia: Saunders; 1995.8. Fallon-Friedlander S, Eichenfield LF. Congenital Infections. In: Demis DJ, ed. ClinicalDermatology. Philadelphia: Lippincott; 1995.9. Eichenfield LF, Friedlander SF. Impetigo. In: Arndt K, ed. Dermatology for the PrimaryPractitioner. Philadelphia: Saunders; 1997.10. McEwen G, Eichenfield LF. Erythema multiforme. In: Burg FD, Ingelfinger JR, Wald ER, PolinRA, eds. Current Pediatric Therapy. 16 th Edition. Philadelphia: Saunders; 1999.11. Eichenfield LF. Pediatric anesthesia and sedation. In: Harper J, Orange A, Prose N, eds. Textbookof Pediatric Dermatology. Blackwell Science; 2000:1817-1823.12. Eichenfield LF, Editor, Textbook of Neonatal Dermatology. Frieden IJ, Esterly NB, Eds. WBSaunders Company, Philadelphia. 2001.13. Eichenfield LF. Dermatophytes and other superficial fungi. In: Long SS, Prober CG,Pickering LK, eds. Principles and Practices of Pediatric Infectious Disease. Philadelphia:Churchill Livingston; 2002.14. Williams JV, Fallon-Friedlander S, Eichenfield LF. Skin. In: Rudolph A, Kamei R, Overby K,eds. Rudolph's Fundamentals of Pediatrics. 3rd Edition. McGraw-Hill; 2002:437-465.15. Eichenfield LF. Neoplastic and proliferative disorders in skin. In: Rudolph C, Rudolph A,Hostetter, M, Lister, G, Siegel, N, eds. Rudolph's Pediatrics. 21st edition. McGraw-Hill;2002:1202-1203.16. Chen B, Eichenfield LF. Acne. In Gellis & Kagan's Current Pediatric Therapy 18. Burg FD,Piolin RA, Ingelfinger JR, Gershon A, Eds. Harcourt Health Sciences 2002, 894-896.17. Eichenfield LF. Cutaneous vascular malformations (port wine stains). In: Stockman, Lohr, Eds.Essence of Office Pediatrics. Harcourt; 2001:97.18. Al-Suwaidan S, Eichenfield LF. Port wine stains (capillary malformations). In: Lebwohl,Heymann, Berth-Jones, Coulson, eds. Treatment of Skin Disease. Harcourt; 2002:496-498.19. Eichenfield LF, Larralde de Luna M. Neonatal skin and skin disorders. In: Schachner, Hansen,eds. Pediatric Dermatology. 3rd edition. Harcourt; 2003:205-254.20. The Eczemas. Eichenfield LF and Leung DMY. Marcel Dekker/Summit Inc. 200421. Pediatric Eczemas. Leung DMY and Eichenfield LF. Marcel Dekker/Summit Inc. 2004Page 27 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.22. Eichenfield LF. Disorders of eccrine and apocrine glands. In: Rudolph C, Rudolph A, Hostetter,M, Lister, G, Siegel, N, eds. Rudolph's Pediatrics. 21st edition. McGraw-Hill; 2002:1215.23. Chen B, Eichenfield LF. Acne. In: Burg FD, Polin RA, Ingelfinger JR, Gershon A, eds. Gellisand Kagan's Current Pediatric Therapy. 17th edition. Saunders; 2002:894-896.24. Eichenfield LF. Disorders with malignant potential (clinical pearls). In: Genodermatoses – aclinical guide to genetic skin disorders. Joel L. Spitz, M.D. Lippincott Williams and Wilkins;2005:171-192.25. Eichenfield LF, Connelly EA. Máculas Hiperpigmentadas (Hyperpigmented Macules). In: Casabéand Valverde, eds. Dermatologia Neonatal, 1a Edición. Artes Gráficas Buschi SA; 2005:209-21826. Salim A, Eichenfield LF. Atopic Dermatitis. In: Rackel, Bope, eds. Conn's Current Therapy, 2006edition. Saunders Elsevier; 2006:1038-1041.27. Roberts BJ, Eichenfield LF. Port wine stains. In: Lebwohl, Heymann, Berth-Jones, Coulson, eds.Treatment of skin disease-comprehensive therapeutic strategies, 2nd edition. Mosby Elsevier;2006:517-519.28. Morel K, Connelly L, Eichenfield LF. Dermatology. In: Fetal & Neonatal Secrets. 2nd Edition.Hancey & Belfus eds. 2006.------------------------------29. Bernard L, Eichenfield LF. Drug-Associated Rashes. In: Zaoutis and Chiang, eds. ComprehensivePediatric Hospital Medicine. Mosby/Elsevier, 2007:1005-1011.30. Leung DYM, Eichenfield LF, Boguniewicz M. Atopic Dermatitis (Atopic Eczema). In: Wolff,Goldsmith, Katz, Gilchrest, Paller, Leffell, eds. Fitzpatrick's Dermatology in General Medicine.7th Edition. McGraw-Hill, 2007:146-157.31. Senior Editor, Neonatal Dermatology, 2nd Edition. Eichenfield LF, Frieden IJ, Esterly NB, eds.Saunders/Elsevier, Philadelphia. 2008.32. Pang ML, Eichenfield LF. Acne. In: Neinstein, Gordon, Katzman, Rosen, Woods, eds. Handbookof Adolescent Health Care. Lippincott Williams & Wilkins. 2009:189-198.33. Pang ML, Eichenfield LF. Miscellaneous Dermatologic Disorders. In: Neinstein, Gordon,Katzman, Rosen, Woods, eds. Handbook of Adolescent Health Care. Lippincott Williams &Wilkins. 2009:199-21334. Pang ML, Eichenfield LF. Acne. In: Neinstein, Gordon, Katzman, Rosen, Woods, eds. In:Adolescent Health Care A Practical Guide, 5th Edition. Lippincott Williams & Wilkins.2009:299-308.35. Pang ML, Eichenfield LF. Acne. In: Neinstein, Gordon, Katzman, Rosen, Woods, eds. In:Adolescent Health Care A Practical Guide, 5th Edition. Lippincott Williams & Wilkins. 2009:309-326.Following have been updated (previously ―in press‖):36. Krakowski AC, Eichenfield LF. Atopic Dermatitis. In: Lebwohl MG, Heymann WR, Berth-Jones Jand Coulson I, eds. Treatment of Skin Disease, 3rd Edition. 2010:56-64.Page 28 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.37. Metz B, Eichenfield LF. Port Wine Stains. In: Lebwohl MG, Heymann WR, Berth-Jones J andCoulson I, eds. Treatment of Skin Disease, 3rd Edition. 2010:590-59238. Chayavichitsilp P, Eichenfield LF. Diaper Dermatitis. In: Lebwohl MG, Heymann WR, Berth-Jones J and Coulson I, eds. Treatment of Skin Disease, 3rd Edition. 2010: 183-184-----------------------------39. .Leung DYM, Eichenfield LF, Boguniewicz M. Atopic Dermatitis (Atopic Eczema). In:Goldsmith, Katz, Gilchrest, Paller, Leffell, Wolff, eds. Fitzpatrick‘s Dermatology in GeneralMedicine. Eighth Edition. McGraw-Hill. 2012:165-182.40. Krakowski AC, Eichenfield LF. The Use of Resurfacing, Pigment and Depilation Lasers inChildren. In: Irvine, Hoeger, Yan, eds. Harper, Oranje, Prose - Harper‘s Textbook of PediatricDermatology. Third Edition. Wiley-Blackwell. 2011: 189.1-189.10.41. Chan YC, Eichenfield LF. Sedation and Anaesthsia. In: Irvine, Hoeger, Yan, eds. Harper, Oranje,Prose - Harper‘s Textbook of Pediatric Dermatology. Third Edition. Wiley-Blackwell.2011:190.1-190.10.42. Eichenfield LF, Lee PW. Neonatal skin and skin disorders – Fetal and neonatal skin development,structure and function. In: Schachner, Hansen, eds. Pediatric Dermatology. Fourth Edition.Mosby Elsevier. 2011: 299-301.43. Eichenfield LF, Lee PW. Neonatal skin and skin disorders – Transient physiologic changes andcutaneous lesions in the newborn. In: Schachner, Hansen, eds. Pediatric Dermatology. FourthEdition. Mosby Elsevier. 2011:301-308.44. Eichenfield LF, Lee PW. Neonatal skin and skin disorders – Infectious diseases of the newborn.In: Schachner, Hansen, eds. Pediatric Dermatology. Fourth Edition. Mosby Elsevier. 2011: 342-359.45. Eichenfield LF, Lee PW. Neonatal skin and skin disorders – Prenatal injury, birth trauma andinjury in the neonatal period. In: Schachner, Hansen, eds. Pediatric Dermatology. Fourth Edition.Mosby Elsevier. 2011: 359-370.46. Eichenfield LF, Lee PW. Neonatal skin and skin disorders – Prenatal Diagnosis. In: Schachner,Hansen, eds. Pediatric Dermatology. Fourth Edition. Mosby Elsevier. 2011: 370-372.47. Eichenfield LF, Lee PW. Neonatal skin and skin disorders – Skin care of newborn infants. In:Schachner, Hansen, eds. Pediatric Dermatology. Fourth Edition. Mosby Elsevier. 2011: 372-373.48. Reyes M, Eichenfield LF. Purpuric Conditions. In: Long, Pickering, Prober, eds. Principles andPractice of Pediatric Infectious Diseases. Fourth Edition. Elsevier. 2012 (In Press).49. Kalavala M, Eichenfield LF. Pitiriasis liquenoide. In: Dermatología pediatrician. Larralde, Abad,Luna, eds. Segunda edición. Ediciones journal. 2010:411-414.------------------------------New50. Piggott CDS, Eichenfield LF, Lucky AW. AARS Acne Treatment Guidelines - Acne in children.In: Acne Vulgaris. Shalita, Del Rosso, Webster, eds. informa healthcare. 2011:182-197.Page 29 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.MISCELLANEOUS PUBLICATIONS1. Eichenfield LF. The rigorous road of a young M.D. The Sunday Boston Globe, pp 41-43; July 26,1987.2. Eichenfield LF, Friedlander SF. Chronic dermatitis. Contemporary Pediatrics. 1998.3. Golkar L, Eichenfield LF. Xerosis and Systemic Disease: Are you undertreating your dry skinpatients? Skin & Aging 1998:35-38.4. Eichenfield LF. Practical insights on managing pediatric atopic dermatitis. Skin & Aging 1998;October:30-36.5. Eichenfield LF. Clinical presentation and pathophysiology of atopic dermatitis. Skin & AllergyNews 2003; February:15-21.6. Eichenfield LF, Lucky AW, Langly RG, Lynde C, Kaufmann R, Tood G, Lindsley L, Barbier N,Felser JM. Use of Pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis ininfants and children: the effects of ethnic origin and baseline disease severity on treatmentoutcome. International Journal of Dermatology 2005 Jan; 44(1):70-75.7. Dohil M, Eichenfield LF. Atopic dermatitis – treatment update. California Pediatrician Spring2005; 21(1):18-19.8. Eichenfield LF. New developments in pediatric dermatology. Supplement to Skin and Aging2005; February:19-20.9. Eichenfield LF. Advances in topical immunomodulators. Supplement to Skin and Aging 2005;February:21-22.10. Eichenfield LF, Miller BH. Two randomized, double-blind, placebo-controlled studies offluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from 3months of age. Journal of American Academy of Dermatology. 2006 Apr;54(4):715-7 (movedto 102a – categorized incorrectly previous version).------------------------------11. Barrio VR, Eichenfield LF. The benefits and risks of atopic dermatitis treatments. TouchBriefings: US Dermatology Review 2006.12. Eichenfield LF. Long-term treatment of atopic dermatitis: analyzing the risks and benefits.Supplement to Pediatric News and Skin and Allergy News 2006; July.13. Del Rosso JQ, Eichenfield LF. Dermatology Challenges: A Pictorial Guide. American Academyof CME, Inc. May 8, 2007.14. Eichenfield LF. Exploring the role of genetics in atopic dermatitis. Journal Scan. Supplement toskin and allergy news. January, 2009.15. The safety and efficacy of cutivate lotion in the treatment of atopic dermatitis in adult andpediatric patients. Touch briefings 2008; 17-18.Page 30 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.ABSTRACTS, POSTER PRESENTATIONS1. Sternal malformation and vascular dysplasia association: additional patients, furthercomplications, and discussion of inheritance. Kline AD, McDonald-McGinn DM, Ross N,Eichenfield LF, Honig P, Templeton Jr JM, Zackai EH. American Society of Human Genetics.1990 (Abstract).2. Subglottic hemangioma associated with a cleft sternum. Tom LWC, Boucher RM, EichenfieldLF. American Academy of Otolaryngology-Head Neck Surgery Annual Meeting. September,1991 (Abstract).3. Anogenital warts in prepubertal children: human papillomavirus epidemiology and assessmentof abuse. Sinclair T, Anders B, Kaufheld L, Newsome L, Eichenfield LF. Western Society forPediatric Research. February, 1993 (Abstract).4. Treatment of functionally significant hemangiomas with systemic glucocorticoids and pulseddyelaser. Eichenfield LF. Society for Pediatric Dermatology. Snowmass, CO. August, 1993(Poster).5. A female infant with microphthalmia with linear skin defects (MLS) and histiocytoidcardiomyopathy of infancy (HCI): a clue to the etiology of HCI? Bird LM, Krous HF,Eichenfield LF, Stalwell CI, Jones MC. Submitted to March of Dimes Clinical GeneticsConference/American College of Medical Genetics Meeting. Kissimmee, FL. March, 1994(Abstract).6. Combined treatment of functionally significant hemangiomas with flashlamp-pumped pulseddye laser and systemic glucocorticoids. American Society for Dermatologic Surgery. SanDiego, CA. May, 1994 (Abstract).7. Vascular telangiectasia/angioma presentation of neonatal lupus. Thornton C, Eichenfield LF,Siegfried E. Rabinowitz L, Esterly N, Friedlander SF. Society for Pediatric Dermatology.Hilton Head, SC. June, 1994 (Poster).8. Telangiectasia/angioma presentation of neonatal lupus. Thornton C, Eichenfield LF, SiegfriedE, Rabinowitz L, Esterly N, Friedlander SF. American Academy of Dermatology AnnualMeeting, New Orleans, LA. February, 1995 (Poster).9. Cotton-swab culture method for the diagnosis of tinea capitis. Eichenfield LF, Pickering B,Fallon-Friedlander S. Ambulatory Pediatrics Meeting, San Diego, CA. May, 1995. ArchPediatric Adolescent Med 1995;149:Supp 126-7 (Abstract).10. Laser treatment of vascular lesions in children: a biologic/technologic approach. LEOS (LaserElectro-Optics Society) Annual Meeting, San Francisco, CA. October, 1995 (Abstract).11. Congenital piezogenic-like pedal papules. Eighth International Congress PediatricDermatology, Paris, France. Ann Dermatology 1998;125(S1):182 (Poster).12. Acanthosis nigricans: marker of metabolic abnormalities in children and adolescents. EighthInternational Congress Pediatric Dermatology, Paris, France. Ann Dermatology1998;125(s1):33. May, 1998 (Abstract).Page 31 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.13. Cotton swab technique for obtaining cultures in patients with suspected tinea capitis. EighthInternational Congress Pediatric Dermatology, Paris, France. Ann Dermatology1998;125(S1):53. May, 1998 (Abstract).14. Topically applied tacrolimus ointment vs. vehicle ointment in pediatric patients with atopicdermatitis. American Academy of Dermatology Annual Meeting. March, 2000 (Poster).15. Complications of general anesthesia in pediatric patients undergoing dermatologic surgicalprocedures. American Society for Dermatologic Surgery. Denver, CO. November 5, 2000(Abstract).16. Low blood concentrations of SDZ ASM 981 in infants with extensive atopic dermatitis treatedwith cream 1%. American Academy of Dermatology Annual Meeting. March, 2001 (Poster).17. Safety, pharmacokinetics, tolerability and efficacy of topical SDZ ASM 981. InternationalSymposium on Atopic Dermatitis. September, 2001 (Abstract).18. Effect of a single course of accutane® therapy on bone mineral density (BMD) in pediatricpatients with severe, recalcitrant, nodular acne (Poster).19. Use of Protopic ointment in atopic dermatitis patients with limited disease. American Academyof Dermatology Annual Meeting. New Orleans, LA. February, 2002 (Abstract and Poster).20. Pimecrolimus (SDZ ASM 981) cream is safe in the long-term control of atopic dermatitis.American Academy of Dermatology Summer Meeting. July 29, 2001 (Abstract).21. Potential role of pimecrolimus as maintenance therapy for atopic dermatitis. Eichenfield LF,Leung D. American Academy of Allergy, Asthma and Immunology Annual Meeting. NewYork, NY. March 1-3, 2002 (Poster).22. Low blood concentrations of SDZ ASM 981 in infants treated with cream 1%. Wahn U, PariserD, Gottlieb AB, Kaufmann R, Eichenfield LF, Langely R, Bueche M, Barilla D, Ebelin ME.International Symposium on Atopic Dermatitis. Portland, OR. September 6-9, 2001 (Abstract).23. Safety, pharmacokinetics, tolerability, and efficacy of topical SDZ ASM 981 (pimecrolimus)and FK 506 (tacrolimus) in pediatric atopic dermatitis: a comparison of clinical studies.Eichenfield LF, Bernard LB. International Symposium of Atopic Dermatitis. Portland, OR.September 6-9, 2001 (Abstract).24. Gluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even inpeanut-sensitive patients. Dohil M, Paller AS, Nimmagadda S, Eichenfield LF. Ann DermatolVenereol 2002; 129:1S211-1S285 (Abstract).25. Pimecrolimus (SDZ ASM 981) cream 1% is safe in the long-term management of atopiceczema. Boguniewicz M, Eichenfield LF, Honig P, Langley R, Lucky A, Paller A, Marshall K,Bush C, Cherill R, Graeber M. The 10th Congress of European Academy of Dermatology andVenereology (EADV). Munich, Germany. October 10-14, 2001 (Abstract and Poster).26. Port-wine stain: neonatal management. Eichenfield LF. Ann Dermatol Venereol 2002;129:1S211-1S285 (Abstract).27. Elidel® in clinical practice: 9-months experience in the USA. Eichenfield LF. EuropeanAcademy of Dermatology and Venereology JEADV 2002; 97:15(Suppl1) (Abstract).Page 32 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.28. Pediatric dermatology in the USA. Eichenfield LF. Dermatology from young to old. June 12-15, 2003. Rotterdam (Abstract).29. Classification of vascular abnormalities. Eichenfield LF. Dermatology from Young to Old. June12-15, 2003. Rotterdam (Abstract).30. Topical Corticosteroids. Eichenfield LF. Dermatology from young to old. June 12-15, 2003.Rotterdam (Abstract).31. Molluscum contagiosum in children – who gets them? Dohil M, Paller A, Lucky A, Lee J,Eichenfield LF. Society for Pediatric Dermatology 29th Annual Meeting. June 18-21, 2003(Poster).32. Successful treatment of intractable pruritus with transcutaneous electrical nerve stimulation(TENS) in children with atopic dermatitis. Shainhouse T, Bergman J, Cunningham B,Friedlander SF, Eichenfield LF. Society for Pediatric Dermatology 29th Annual Meeting. June18-21, 2003 (Poster).33. Pimecrolimus (SDZ ASM 981) blood levels are consistently low in children with extensiveatopic eczema. Harper J, Lakhanpaul M, Wahn U, Pariser D, Gottlieb AB, Kaufmann R,Eichenfield LF, Langley R, Scott G, Ebelin ME, Burtin P. The 10th Congress of the EuropeanAcademy of Dermatology and Venereology (EADV). Munich, Germany. October 10-14, 2001(Abstract and Poster).34. Safety and efficacy of topical tacrolimus ointment (Protopic®) in young children 2 to 6 years ofage with atopic dermatitis. Leung D, Eichenfield LF. American Academy of DermatologyAnnual Meeting. New Orleans, LA. February, 2002.35. Long-term safety of topically applied tacrolimus ointment (Protopic®) in pediatric patients 2-15 years of age with atopic dermatitis. Paller A, Hanifin J, Eichenfield LF, et al. AmericanAcademy of Dermatology Annual Meeting. New Orleans, LA. February, 2002 (Poster).36. Double-blind, randomized, placebo-controlled, multicenter study to assess two strengths oftretinoin microsphere gel (TMG) in the treatment of acne vulgaris. Eichenfield LF, et al.American Academy of Dermatology Annual Meeting. New Orleans, LA. February, 2002(Abstract).37. Double-blind, randomized, vehicle-controlled, multicenter study to assess the safety andefficacy of tretinoin microsphere gel (TMG) 0.04% in the treatment of acne vulgaris. Berger R,Eichenfield LF, et al. American Academy of Dermatology Annual Meeting. New Orleans, LA.February, 2002 (Abstract).38. Use of tacrolimus ointment in atopic dermatitis patients with limited disease. Leung D,Eichenfield LF, Fleischer A, Korman N, Paller A, Rico MJ, Satoi Y, Maher R. AmericanAcademy of Dermatology Annual Meeting. February 22-27, 2002 (Poster).39. Validation of the eczema area and severity index (EASI) for atopic dermatitis in 1,533 patientsfrom the pimecrolimus 1% cream clinical programme. Hanifin J, Allen R, De Prost Y, Luger T,Eichenfield LF, et al. Ann Dermatol Venereol 2002; 129:1A371-1S602 (Abstract).40. Pimecrolimus (SDZ ASM 981) cream is effective in patients aged 3 months to 17 years withatopic dermatitis. Lucky A, Ho V, Boguniewicz M, Gupta A, Kaufmann R, Ling M, Todd G,Eichenfield LF, et al. Ann Dermatol Venereol 2002; 129:1S371-1S602 (Abstract).Page 33 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.41. Pimecrolimus in clinical practice: guidelines for use. Eichenfield LF. Ann Dermatol Venereol2002; 129:1S81-1S141 (Abstract).42. 5% 5-fluorouracil cream for the treatment of common warts in children. Gladsjo JA, Alio A,Kricorian G, Bergman JN, Friedlander SF, Eichenfield LF, Dohil M, Funk A, Holland SE,Cunningham BB. American Academy of Dermatology Summer Meeting 2004. New York, NY(Poster).43. A pilot, randomized, double-blind, vehicle-controlled parallel-group, multicenter study todetermine the safety and efficacy of concomitant use of locoid lipocream cream in Elidelcream-treated subjects with mild to moderate atopic dermatitis. Schachner L, Eichenfield LF,Smith S, Dromgoole S. American Academy of Dermatology Annual Meeting. February 18-22,2005 (Poster).44. An open-label, adrenal suppression study of hydrocortisone butyrate 0.1% lipocream used threetimes daily in children 5-12 years old with moderate to severe eczema or atopic dermatitis.Eichenfield LF, Ellis C, Fivenson D, Hebert A. American Academy of Dermatology AnnualMeeting. February 18-22, 2005 (Poster).45. Fluticasone propionate (FP) emulsion (0.05%): an advance in topical preparations. Miller BH,Eichenfield LF. American Academy of Dermatology Annual Meeting. February 18-22, 2005(Abstract).46. An open-label, adrenal suppression study of hydrocortisone butyrate 0.1% lipocream used threetimes daily in children 5-12 yrs old with moderate to severe eczema or atopic dermatitis.Eichenfield LF. American Academy of Dermatology Annual Meeting. February 18-22, 2005(Poster).47. Pulmonary thromboembolism associated with Klippel-Trenaunay syndrome. Huiras EE, BarnesCJ, Eichenfield, LF, Pelech AN, Drolet BA.Pediatrics 2005;116:e596-e600. URL:www.pediatrics.org/cgi/doi/10.1542/peds.2004-1607 (Abstract).48. Chiang C, Eichenfield LF. Quantitative measurement of bathing and moisturizer inducedchanges in skin hydration in atopic dermatitis subjects. Society for Investigative Dermatology.Philadelphia. May, 2006 (Abstract and Poster).49. Safety of desonide gel, 0.05% in a hypothalamic-pituitary-adrenal axis suppression study ofchildren with atopic dermatitis. American Academy of Pediatrics. Atlanta. October, 2006(Abstract).50. Clindamycin phosphate foam, 1% for the treatment of acne vulgaris: subanalysis in adolescents.American Academy of Pediatrics. Atlanta. October, 2006.------------------------------51. Comparative absorption of 0.25% and 2% miconazole nitrate preparations in infants withdiaper dermatitis. American Academy of Dermatology Annual Meeting. Washington, DC.February, 2007 (Abstract & Poster accepted).52. A randomized, double blind, placebo controlled, parallel group study of nanocrystalline silver(NPI 32101) cream in pediatric atopic dermatitis (AD). American Academy of DermatologyAnnual Meeting. Washington, DC. February, 2007 (Abstract and Poster accepted).Page 34 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.53. The demographic profile of a large population of infants with atopic dermatitis: a longitudinalstudy on the development of asthma and allergies. American Academy of Dermatology AnnualMeeting. Washington, DC. February, 2007 (Abstract and Poster accepted).54. A novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate: efficacy in acnevulgaris patients aged 12 to 18 years. Society for Pediatric Dermatology Annual Meeting.Chicago, IL. July, 2007 (Abstract and Poster accepted).55. An innovative approach to flare prevention and long-term disease control in pediatric patientswith atopic dermatitis: three times weekly applications of tacrolimus ointment . Society forPediatric Dermatology Annual Meeting. Chicago, IL. July, 2007 (Abstract and Posteraccepted).56. Baseline atopic dermatitis profile of over 1000 infants enrolled into a study assessing the effectof pimecrolimus cream 1% on atopic dermatitis and development of asthma and allergies. 21stWorld Congress of Dermatology. Buenos Aires, Argentina. September 30-October 5, 2007(Abstract and Poster accepted).57. A multicenter, double-blind, vehicle-controlled clinical study to evaluate the efficacy andtolerability of MAS063DP (atopiclair/zarzenda) in the management of mile to moderate atopicdermatitis in children and infants. 21st World Congress of Dermatology. September 30 –October 5, 2007 (Abstract accepted).58. Etanercept treatment in children and adolescents with plaque psoriasis. American Academy ofDermatology Annual Meeting. January 31 – February 4, 2008 (Abstract and Poster accepted).59. An innovative approach to flare prevention and long-term disease control in pediatric patientswith atopic dermatitis: three-times weekly applications of tacrolimus ointment. 9th Congress ofthe European Society for Pediatric Dermatology (ESPD). Athens, Greece (Abstract submitted).60. Long-term intermittent use of tacrolimus ointment for flare prevention and disease control inpediatric patients with stabilized atopic dermatitis. American Academy of Dermatology AnnualMeeting. January 31 – February 4, 2008 (Abstract and Poster accepted).61. An open-label, community-based, phase four study to assess facial acne improvement with theuse of tretinoin gel microsphere in a pump dispenser. American Academy of DermatologyAnnual Meeting. January 31 – February 4, 2008 (Abstract and Poster accepted).62. DermBridge: developing a core dermatological curriculum for the next generation ofphysicians. American Academy of Dermatology Annual Meeting. January 31 – February 4,2008 (Abstract and Poster accepted).63. Comparison of a 3-step acne system containing solubilized benzoyl peroxide versus benzoylperoxide/clindamycin: a multicenter, investigator-blind, randomized study. American Academyof Dermatology Annual Meeting. January 31 – February 4, 2008 (Abstract and Posteraccepted).64. Etanercept treatment in children and adolescents with plaque psoriasis. Winter ClinicalDermatology Conference. March 14-18, 2008 (Poster Submitted).65. Epiceram for the treatment of mild-moderate atopic dermatitis – a pilot study. Posterpresentation. 5th George Rajka International Symposium of Atopic Dermatitis, Kyoto, Japan.May, 2008.Page 35 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.66. Etanercept treatment for children and adolescents with plaque psoriasis. CanadianDermatology Association (CDA) Annual Meeting. Montreal, Canada. June 27-July 2, 2008(Poster)67. A topical physiologic, lipid-based, barrier repair formulation (EpiCeram® Emulsion) is highlyeffectivemonotherapy for pediatric atopic dermatitis. 34th Annual Meeting, Society forPediatric Dermatology. Snowbird, Utah. July 9-12, 2008 (Poster).68. Safety and adverse effects of isotretinoin in the pediatric dermatology clinical setting. 34thAnnual Meeting, Society for Pediatric Dermatology. Snowbird, Utah. July 9-12, 2008 (Poster).69. Evaluating the tolerance and efficacy of a colloidal oatmeal cream and cleanser in infants andchildren with atopic dermatitis. 34th Annual Meeting, Society for Pediatric Dermatology.Snowbird, Utah. July 9-12, 2008 (Poster).70. Addition of pimecrolimus cream 1% to the treatment of severe pediatric atopic dermatitis withtopical corticosteroids yielded a comparable safety profile. 17th European Academy ofDermatology and Venereology (EADV) Conference. Paris, France. September 15-19, 2008(Abstract and Poster).71. Long-term intermittent use of tacrolimus ointment as maintenance treatment for flareprevention I pediatric patients with stabilized atopic dermatitis. 17th European Academy ofDermatology and Venereology (EADV) Conference. Paris, France. September 15-19, 2008(Abstract and Poster).72. Effect of etanercept treatment on nail psoriasis in children and adolescents. 17th EuropeanAcademy of Dermatology and Venereology (EADV) Conference. Paris, France. September 15-19, 2008 (Abstract and Poster).73. Etanercept Treatment in Children and Adolescents with Plaque Psoriasis. 27th Fall ClinicalDermatology Conference, Las Vegas, NV. October 16-19, 2008 (Abstract and Poster).74. Concomitant use of topical corticosteroids (TCS) and pimecrolimus cream 1% in the treatmentof severe pediatric atopic dermatitis has a safety profile comparable to TCS alone. AmericanAcademy of Dermatology 67th Annual Meeting. San Francisco, CA. March 6-10, 2009(Abstract and Poster).75. Managing moderate to severe acne in adolescents: benefits of a fixed combination clindamycinphosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in asubpopulation of 1,755 subjects. American Academy of Dermatology 67th Annual Meeting.San Francisco, CA. March 6-10, 2009 (Abstract and Poster).76. An innovative approach to flare prevention and long-term disease control in pediatric patientswith atopic dermatitis: three times weekly applications of tacrolimus. Pediatric AcademySociety Annual Meeting. Baltimore, MD. May 2-5, 2009 (Abstract and Poster).77. Elevated IgE in children with eczema – significant or not? Society for Pediatric Dermatology35th Annual Meeting. Philadelphia, PA. July 10-11, 2009 (Abstract and Poster).78. Elevated IgE in children with eczema – significant or not? American Academy of DermatologySummer Academy Meeting. Boston, MA. July 29 – August 2, 2009 (Abstract and Poster).Page 36 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.79. When there is insufficient evidence: consensus expert advice via "The Delphi Technique" formanagement of difficult atopic dermatitis cases in children. American Academy ofDermatology Summer Academy Meeting. Boston, MA. July 29 – August 2, 2009 (Abstract andPoster).80. CA-MRSA skin infection is less likely in children with atopic dermatitis. American Academyof Dermatology Summer Academy Meeting. Boston, MA. July 29 – August 2, 2009 (Abstractand Poster).81. New tools in the evaluation and management of atypical spitzoid lesions. American Academyof Dermatology Summer Academy Meeting. Boston, MA. July 29 – August 2, 2009 (Abstractand Poster).------------------------------82. An open-label study to assess efficacy and tolerability of tretinoin gel microsphere 0.04% I apump dispenser in early and pre-adolescents. American Academy of Dermatology AnnualMeeting. Miami Beach, FL. March 5-10, 2010 (Poster).83. Micronized inorganic UV filter sunscreen use appears safe and efficacious in babies andchildren. American Academy of Dermatology Annual Meeting. Miami Beach, FL. March 5-10,2010 (Poster).84. A 3-step acne system containing solubilized benzoyl peroxide versus benzoyl peroxideclindamycinin pediatric patients with acne. American Academy of Dermatology AnnualMeeting. Miami Beach, FL. March 5-10, 2010 (Poster).85. Specific IgE levels in a cohort of infants with atopic dermatitis do not predict the developmentof food allergy. American College of Allergy, Asthma and Immunology Meeting (ACAAI).Phoenix, AZ. November 11-16, 2010 (Poster).86. .A pilot study of tretinoin microsphere gel, 0.04% pump, in the treatment of acne vulgaris inchildren aged 9 to 11 years. Winter Clinical Dermatology Conference. Kohala Coast, HI.January 14-19, 2011.87. A pilot study of tretinoin microsphere gel, 0.04% pump, in the treatment of acne vulgaris inchildren aged 9 to 11 years. Orlando Dermatology Aesthetic and Clinical Conference.Orlando, FL. November 9-12, 2011.SELECTED PRESENTATIONS1. "Teaching Residents to be Teachers." Fifth Annual Pediatric Chief Residents/ProgramDirectors Conference. A.I. DuPont Institute, Wilmington, DE. April, 1988.2. "A Look at Residency Education." Children's Hospital Alumni Reunion Program. Philadelphia,PA. May, 1988.3. "Alagille Syndrome with a Photosensitive Eruption." Society for Pediatric Dermatology AnnualMeeting. Gleneden Beach, OR. July, 1988.4. "Acrodermatitis Enteropathica-like Eruption with Cystic Fibrosis." Society for PediatricDermatology Annual Meeting, Quebec City, Quebec. June, 1989.Page 37 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.5. "Update on Viral Exanthems." Pediatric Grand Rounds. Montgomery Hospital Medical Center,Norristown, PA. October, 1989.6. "AIDS: From the Test Tubes to the Trenches." Amherst College Symposium, Amherst, MA.June, 1990.7. "Aplasia Cutis Congenita Associated with Fetus Papyraceous." Society for PediatricDermatology Annual Meeting, San Diego, CA. August, 1990.8. "Sternal Malformation Associated with Craniofacial Hemangiomas." Society for PediatricDermatology Annual Meeting. San Diego, CA. August, 19909. " Applications of New Molecular Biologic Techniques to Dermatology Practice." PennsylvaniaAcademy of Dermatology Annual Meeting. Hershey, PA. September, 1990.10. "Update of Viral Exanthems." Pediatric Grand Rounds. Mount Sinai Medical Center, NewYork, NY. April, 1991.11. "Hemangiomas: Advances in Diagnosis and Treatment." Advances in Dermatology: Mexico-United States Binational Symposium. September, 1991.12. "What's New in Pediatric Dermatology." Mercy Hospital Pediatric Grand Rounds. San Diego.June, 1992.13. "Update in Pediatric Dermatology." Kaiser-Bellflower Medical Grand Rounds. Los Angeles,CA. July, 1992.14. Symposium on Clinical Pediatric Problems. Guest Faculty. Kaiser Permanente, Stockton, CA.September, 1992.15. "Pediatric Dermatology: Lasers and Other Hot Topics." Children's Hospital of PhiladelphiaAlumni Organization Program. October, 1992.16. "Pediatric Dermatology Update." Kaiser Dermatology Symposium. Los Angeles, CA. October,1992.17. "Aleukemic Leukemia Cutis." Fallon-Friedlander S, West A, Eichenfield LF. Society forPediatric Dermatology. Snowmass, Colorado. August, 1993.18. "Henoch Schonlein Purpura with Pulmonary Vasculitis." Goskowicz M, Eichenfield LF.Society for Pediatric Dermatology. Snowmass, Colorado. August, 1993.19. "Flashlamp-Pumped Dye Laser Therapy of Vascular Lesions in Children." Laser Electro-OpticsSociety Meeting. San Jose, CA. November, 1993.20. "Update on the Treatment of Hemangiomas." Pediatric Grand Rounds. Kaiser Permanente, SanDiego, CA. November, 1993.21. "Skin Cancer in Children and Adolescents." Skin Cancer Update, Scripps Institute CMECourse. San Diego, CA. January, 1994.22. "Anogenital Warts: Facts & Controversies." San Diego Conference on Responding to ChildMaltreatment. San Diego, CA. January, 1994.23. "Combined Treatment of Functionally Significant Hemangiomas with Flashlamp-PumpedPulsed Dye Laser and Systemic Glucocorticoids." American Society for Dermatologic Surgery.San Diego, CA. May, 1994.Page 38 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.24. "Analgesia and Anesthesia for Pediatric Dermatology Procedures." Society of PediatricDermatology Annual Meeting. Hilton Head, NC. June, 1994.25. "Hemangiomas and Other Vascular Lesions." Kaiser Permanente Southern CaliforniaDermatology Conference. San Diego, CA. June, 1994.26. "Pediatric Dermatology." Family Medicine Update: 1994. San Diego Academy of FamilyPhysicians. San Diego, CA. July, 1994.27. The 36 th Annual Pediatrics Symposium. Guest Faculty. Southern California Kaiser Permanente.Pasadena, CA. October, 1994.28. Dermatology Grand Rounds: "Adolescent Dermatoses." Loma Linda University School ofMedicine. Loma Linda, CA. October, 1994.29. "Cutaneous Malignancies: 1994 Skin Cancer Update." Scripps Clinic CME Course. November,1994.30. "Recent Research on Anogenital Warts." The San Diego Conference on Responding to ChildMaltreatment. San Diego, CA. January, 1995.31. "Skin Manifestation of Neurofibromatosis." A Neurofibromatosis Symposium., NationalNeurofibromatosis Foundation, Inc. San Diego, CA. January, 1995.32. ―Vascular Malformations and Hemangiomas in Children.‖ Grand Rounds, Kaiser PermanenteDepartment of Family Practice. San Diego, CA. April, 1995.33. "Recent Advances in Pediatric Dermatology." Invited Lecturer: Annual Meeting of the BajaCollege of Pediatrics, Tijuana Chapter. Tijuana, Mexico. September, 1995.34. "Hemangiomas and Vascular Malformations." Grand Rounds, Children's Hospital of OrangeCounty, Department of Pediatrics. Orange, CA. September, 199535. "Blistering Eruptions" and "Common Adolescent Dermatoses." Invited Faculty. PracticalPediatrics, 1995. Seattle Children's Hospital/University of Washington. Invited Faculty.Seattle, Washington. October, 1995.36. "Laser Treatment of Vascular Lesions in Children: A Biologic/Technologic Approach." InvitedLecturer. LEOS (Laser Electro-Optics Society) Annual Meeting, San Francisco, CA. October,1995.37. "Melanoma in Children and Adolescents." Melanoma 1995 – Sixth Annual CutaneousMalignancy Update. Scripps Clinic and Research Foundation. San Diego, CA. November, 199538. The 5 th Biennial "Practical Pediatric Dermatology." Invited Guest Faculty. University ofCalifornia, San Francisco. San Francisco, CA. March, 199639. Grand Rounds, Department of Pediatrics, Mount Sinai School of Medicine. New York, NY.April, 1996.40. Invited Lecturer North American Society for Pediatric and Adolescent Gynecology AnnualMeeting. Workshop Director: "HPV in Children.". San Diego, CA. May, 1996.41. Vermont Summer Pediatric Seminar. University of Vermont College of Medicine. ManchesterVillage, VT. June, 1996.42. Grand Rounds, St. Louis Dermatology Society and St. Louis University Department ofDermatology. St. Louis, MO. July, 1996.Page 39 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.43. "Acanthosis Nigricans and Other Systemic Disease Associations." Society for PediatricDermatology 21 st Annual Meeting. Manchester Village, VT. August, 1996.44. "Mimics of Child Abuse and Neglect." Child Maltreatment Course. San Diego, CA.August, 1996.45. "What's New in Pediatric Dermatology." Orange County Dermatology Society. Orange, CA.September, 1996.46. "Pediatric and Adolescent Dermatology." KPBS Television (2-hour program); San Diego StateUniversity Health Series. San Diego, CA. September, 1996.47. International Symposium on Topical Corticosteroids in Children, (invited paper); Sao Paulo,Brazil. September, 1996.48. Masters of Pediatric Dermatology and Masters of Pediatrics. Guest Faculty. University ofMiami School of Medicine. Miami, FL. January, 1997.49. "What's New in Pediatric Dermatology." Loma Linda, CA. February, 1997.50. Visiting Professor, Department of Dermatology, Mount Sinai School of Medicine, New York,NY. June, 1997.51. "Pediatrics Update." Los Angeles Pediatric Society. Invited Faculty. La Jolla, CA. September,1997.52. Practical Pediatrics 1997. Invited Faculty. Seattle Children's Hospital/University ofWashington. Seattle, WA. October, 1997.53. Grand Rounds, Ohio State University Division of Dermatology. Columbus, OH. November,1997.54. "Melanoma in Children and Adolescents." Melanoma 1998: 8 th Annual Cutaneous MalignancyUpdate. La Jolla, CA. January, 1998.55. "Acanthosis Nigricans: Marker of Metabolic Abnormalities in Children and Adolescents." 8 thInternational Congress Pediatric Dermatology. Paris, France. May, 1998.56. "Cotton Swab Technique for Obtaining Cultures in Patients with Suspected Tinea Capitis." 8 thInternational Congress Pediatric Dermatology. Paris, France. May, 1998.57. 43 rd Great Smoky Mountains Pediatric Seminar. Invited Faculty. University of TennesseeMedical Center at Knoxville. Knoxville, TN. June, 1998.58. Visiting Faculty, St. Louis University Department of Dermatology/St. Louis DermatologySociety. June, 1998.59. Visiting Faculty, Department of Dermatology. SUNY Medical Center, Brooklyn, NY.September, 1998.60. 15 th Annual Current Advances in Pediatrics. American Academy of Pediatrics, Chapter 4.Irvine, CA. October, 1998.61. 18 th International Symposium on Neonatal Intensive Care. Milan, Italy. November, 1998.62. Visiting Professor, Department of Pediatrics. Washington University, St. Louis, MO.November, 1999.Page 40 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.63. Visiting Professor, Tidewater Pediatric Society and Tidewater Dermatology Society CombinedMeeting, and Children's Hospital of the King's Daughter/Eastern Virginia Medical SchoolDepartment of Pediatrics. Norfolk, VA. September, 1999.64. University of Toronto Dermatology Society. October, 1999.65. "Pediatric Dermatology: Surgery and Lasers." San Francisco Dermatology Society.San Francisco, CA. November, 1999.66. "Pediatric Dermatology Update." San Francisco Dermatology Society Meeting. San Francisco,CA. November, 1999.67. "Melanoma in Children and Adolescents." 10 th Annual Melanoma Update 2000: San Diego,CA. January, 2000.68. "Cutaneous Malignancy Update." Scripps Clinic, La Jolla, CA. January 22-23, 2000.69. Symposium on Vascular Anomalies. San Francisco, CA. February, 2000.70. "Advances and Changing Trends." 17 th Annual Pediatrics Seminar. Florida. March, 2000.71. "Neonatal Dermatology." American Academy of Dermatology, 58 th Annual Meeting.San Francisco, CA. March 10, 2000.72. "Pediatric Anesthesia." American Academy of Dermatology, 58 th Annual Meeting.San Francisco, CA. March 11, 2000.73. "Pediatric Surgery." American Academy of Dermatology, 58 th Annual Meeting. San Francisco,CA. March 13, 2000.74. American Academy of Allergy, Asthma and Immunology. San Diego, CA. March, 2000.75. Pediatric Dermatology for the Practitioner. Children's Hospital of Philadelphia. Philadelphia,PA. April, 2000.76. Guest Speaker, Loma Linda. Grand Rounds. April, 2000.77. Spring Symposium, Pediatric Infectious Disease Society. Boston, MA. May, 2000.78. 2000 American Academy of Dermatology Washington Conference. Washington, DC. June,2000.79. California Society for Allergy, Asthma and Immunology. La Costa, CA. August, 2000.80. Hawaii Dermatology Society. Maui, HI. September, 2000.81. 24 th Annual Uniformed Services Dermatology Seminar. San Diego, CA. September, 2000.82. Grand Rounds, Columbia University Department of Dermatology. Chicago, IL. January 17,2001.83. "Atopic Dermatitis: What's New." Skin Disease Education Foundation, Phoenix DermatologyOpen. Phoenix, AZ. January 18-21, 2001.84. "Pediatric Dermatology Surgery Update." Skin Disease Education Foundation, HawaiiDermatology Seminar. Maui, HI. February 3-10, 2001.85. "Pediatric Dermatology," Pediatric Infections," and "Pediatric Surgery." 59 th Annual AmericanAcademy of Dermatology. Washington, DC. March 2-7, 2001.Page 41 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.86. "Rash Suggestions: An Approach to Atopic Dermatitis," "What's New In PediatricDermatology," "Neonatal Dermatology Update," and "Seeing Red: Hemangiomas and VascularMalformations." American Academy of pediatrics, Clinical Pediatrics. Palm Springs, CA.March 15-17, 2001.87. Visiting Professor, Department of Dermatology, Cedars-Sinai Medical Center, Los Angeles,CA. May 3, 2001.88. "Visual Diagnosis of Dermatologic Disorders," "Sun, Moles and Skin Cancer," and "CaseStudies in Dermatology: You Make the Call." Symposia Medicus, Spring Conference onAdolescent Medicine and Nursing. Aruba. May 16-19, 2001.89. Visiting Faculty, Loma Linda Dermatology Department. May 30, 2001.90. "Skin Signs of Systemic Disease." American Academy of Pediatrics Super CME. New York,NY. June 13-16, 2001.91. "Not All Zebras: Pigmented and Hypopigmented Spots and Stripes," "Neonatal Dermatology,""Quit Bugging Me: Infestation/Infection Update," "Sun, Moles and Skin Cancer," and "SeriousSystemic Illnesses and Emergencies in Pediatric Dermatology." American Academy ofPediatrics in the Islands. Maui, HI. July 1-7, 2001.92. "Atopic Dermatitis," and "Pediatric Dermatology." American Academy of Dermatology,Academy 2001. Anaheim, CA. July 31, 2001.93. "Low Blood Concentrations of SDZ ASM 981 in Infants Treated with Cream 1%."International Symposium on Atopic Dermatitis. Portland, OR. September 6-9, 2001.94. Grand Rounds, Baylor University Dermatology Department. Houston, TX. September 25,2001.95. "What's New in Pediatric Dermatology?" "When to Worry: Skin Signs of Systemic Disease,""Rash Suggestions: An Approach to Atopic Dermatitis," and "Neonatal Dermatology."American Academy of Pediatrics, Practical Pediatrics. January 17-20, 2002.96. "Pediatric Safety & Update on Topical Protopic," and "Acne Update: Antibiotic Resistance."26 th Annual Hawaii Dermatology Seminar. January 26, 31, 2002.97. "Neonatal Dermatology." Grand Rounds. University of California, Los Angeles, Division ofDermatology. February 5, 2002.98. "What‘s New in Pediatric Dermatology?" 36 th Annual Uniformed Services Pediatric Seminar.March 10-14, 2003.99. Director "Pediatric Dermatology" Forum. 60 th Annual Meeting of the American Academy ofDermatology . February 20-23, 2002.100. "Immunomodulators and Pediatric Atopic Dermatology." 60 th Annual Meeting of theAmerican Academy of Dermatology. February 20-23, 2002.101. "Controversies in Atopic Dermatitis: Topical Calcineurin Inhibitors-First Line Therapy?""Experience with Immunomodulatory Agents for Treatment of Atopic Dermatitis," "NewTherapeutic Approaches for Inflammatory Dermatoses," and "New Paradigms in thePathophysiology and Treatment of Inflammatory Skin Diseases." American Academy ofAllergy, Asthma and Immunology 58 th Annual Meeting. March 1-4, 2002.102. "Neonatal Dermatology," "Dermatitis," "Vascular Lesions," and "Hemangiomas and VascularMalformations Treatment Update." Sociedad Argentina de Dermatologica. April 4-7, 2002.Page 42 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.103. "Neonatal Dermatology," "What's New in Pediatric Dermatology?" and "Atopic DermatitisUpdate." Visiting Professor. Cincinnati Dermatology Society. Cincinnati, OH. May 1-2, 2002.104. "Common Dermatologic Problems," "Visual Diagnosis of Dermatologic Disorders," "Sun,Moles and Skin Cancer," and "Case Studies in Dermatology: You Make the Call." 13 th AnnualConference on Adolescent Medicine & Nursing. May 15-18, 2002.105. "Recent Advances in Dermatologic Disease: Wart's New?" "Neonatal Dermatology: BeyondCursory in the Nursery," "Rheum with a View: Visual Signs of Systemic Disease," and "AcneUpdate: What's Zit All About?" Vermont Summer Pediatric Seminar. June 13-16, 2002.106. "Beware of the Flare: Improving Atopic Eczema Control with Pimecrolimus." World Congressof Dermatology. July 1-5, 2002.107. "New Questions in Atopic Dermatitis?" American Academy of Dermatology. July 31-August 4,2002.108. "Pediatric Dermatology Update." Los Angeles Metropolitan Dermatological Society, Inc. LosAngeles, CA. September 24, 2002.109. "What's New in Pediatric Dermatology?" and "Management Challenges in Atopic Dermatitis."21 st Anniversary Fall Clinical Dermatology Conference. October 11-14, 2002.110. Visiting Professor, Yale Department of Dermatology. New Haven, CT. November 6, 2002.111. "Newborn Skin Disorders from A to Z," and "Skin Signs of Systemic Disorders." PediatricDermatology Annual Winter Meeting. December 7, 2002.112. "What's New in the Treatment of Childhood Atopic Dermatitis?" Mt. Sinai WinterDermatology Seminar. December 15, 2002.113. "Skin Signs of Systemic Disease," "New Treatments," "Neonatal Dermatology," and"Procedure and Surgery Update." Masters of Pediatrics; Masters of Dermatology, University ofMiami School of Medicine. Miami, FL. January, 2003.114. "Dermatologic Surgery in the Pediatric Population," "Neonatal Dermatology," and "TopicalImmunomodulators." Montana Academy of Dermatology. Big Sky, CO. January, 2003.115. "Advances in Dermatology: What's New?" Case Studies in Dermatology: You Make the Call,and "Skin Signs: When to Worry…When Not." Symposia Medicus. Big Sky, MT. March 2-5,2003.116. "Laser Treatment of Vascular Birthmarks," "Advances in the Long-Term Management ofAtopic Dermatitis," and "Pediatric Surgery." American Academy of Dermatology 61 st AnnualMeeting. San Francisco, CA. March 21-26, 2003.117. "Elidel® in Everyday Practice: 15 Months' Use in the USA." Elidel® in Eczema: From Promiseto Proof. Cannes, France. June 6-8, 2003.118. "Topical Corticosteroids," "Hemangiomas and Vascular Malformations," Classifications ofVascular Abnormalities," and "Abuse and Abuse Mimics." Dermatology from Young to Old.Rotterdam, The Netherlands. June 12-15, 2003.119. "Eczematous Dermatitis: Evolving Therapy." International Conference on Occupational Healthand Contact Allergy. Helsinki, Finland. July 8-13, 2003.120. "Consensus Guidelines for Atopic Dermatitis." International Conference on Food Allergy andAtopic Dermatitis. Milan, Italy. January 21, 2004.Page 43 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.121. "Atopic Dermatitis, What's New?" "Atopic Dermatitis: An Overview," and "VascularBirthmarks: Classification." American Academy of Dermatology. Washington, DC. February6-10, 2004.122. "Topical Steroids: The Fear Factor," and "Atopic Dermatitis Workshop." DermatologyFoundation Clinical Colloquium. February 18-21, 2004.123. Visiting Professor in Dermatology. University of Minnesota, Minneapolis. May, 2004.124. "Atopic Dermatitis" and "Acne and Other Common Adolescent Skin Disorders. Advances inthe Practice of Pediatrics. San Diego, CA. March 5-6, 2004.125. "Topical Steroids: The Fear Factor." Dermatology Foundation Mini Symposia. Amelia Island,FL. March 20, 2004.126. "Neonatal Dermatology." World Congress. Rome, Italy. July 8, 2004.127. "Laser Treatment in Vascular and Pigmented Birthmarks," "Long-Term Management of AtopicDermatitis, and "Advances in Neonatal Dermatology." 16 th Regional Conference ofDermatology. Singapore. July 13, 2004.128. "Emerging Concepts in Pediatric Dermatology." American Academy of Dermatology,Academy '04. New York, NY. July 30, 2004.129. "Advances in Topical Immunomodulators," and "New Developments in PediatricDermatology." Fall Clinical Dermatology Course. Las Vegas, NV. October 9, 2004.130. "Neonatal Dermatology – Birthmarks, Blisters, Red Scaly Babies," "Atopic Dermatitis – AClinician's Approach," and "Dermatology Potpourri." American Academy of Pediatrics. SanFrancisco, CA. October 11, 2004.131. "Hemangiomas and Vascular Malformations" and "Acne." Review of Dermatology RegionalCourse. Phoenix, AZ. November 5-6, 2004.132. "Neonatal Dermatology – Baby Skin A to Z," "What's New in Pediatric Dermatology," "AtopicDermatitis," "Sun, Moles and Skin Cancer," and "Atopic Dermatitis – Itching to Know More."Pediatric Update Conference. Las Vegas, NV. November 19-20, 2004.133. Grand Rounds. Children's Hospital of Philadelphia. Philadelphia, PA. January 5, 2005.134. Grand Rounds. University of Alabama Department of Dermatology. Birmingham, AL. January6, 2005.135. "Pediatric Dermatology Update, Part II." Advances in Cosmetic and Medical Dermatology.January 27, 2005.136. "Atopic Dermatitis Update," and "Newborn Skin Disorders A to Z." Medicis Winter KinSeminar. Snowmass, CO. January 28-29, 2005.137. "Vascular Lesions." Society of Dermatology Physician Assistants CME Symposium. NewOrleans, LA. February 17, 2005.138. "Atopic Dermatitis: Evolving Treatment Paradigms," and "Atopic Dermatitis: Itching to KnowMore." 29 th Annual Hawaii Dermatology Seminar. Wailea, Maui. March 20-24, 2005.139. "Laser and Other Destructive Modalities." Infantile Hemangiomas: Current Knowledge, FutureDirections, National Institutes of Health. Bethesda, MD. April 7-9, 2005.140. "Neonatal Dermatology A to Z." UCSD CME Lecture. San Diego, CA. April 29, 2005.Page 44 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.141. "Atopic Dermatitis-What's New," Neonatal Dermatology A to Z," and "Challenging Cases."Visiting Professor, Vanderbilt University Department of Dermatology. Nashville, TN. June 2,2005.142. ―Neonatal Dermatology.‖ British Society for Paediatric Dermatology. Glasgow, Scotland. July6, 2005.143. ―What‘s New in Paediatric Dermatology.‖ 85 th Annual Meeting, The British Association ofDermatologists. Glasgow, Scotland. July 8, 2005.144. "Atopic Dermatitis – Bench to Bedside." 31 st Annual Meeting, The Society for PediatricDermatology. San Diego, CA. July 13, 2005.145. ―New Insights into the Action of Naturals.‖ Satellite Symposium Dinner Meeting – SummerAAD. Chicago, IL. July 22, 2005.146. "Topical Immunomodulators." Winter Clinical Dermatology Conference. Kapalua, Maui.January 14, 2006.147. What's New in Pediatric Dermatology." Winter Clinical Dermatology Conference. Kapalua,Maui. January 14, 2006.148. "What we Do When Nothing Else Works." Acne/Acne Rosacea: Case Management;Therapeutic Strategies. Advances in Cosmetic & Medical Dermatology. Wailea, Maui.February 5, 2006.149. "Evolving Therapy in Atopic Dermatitis." 30 th Annual Hawaii Dermatology Seminar. Kauai,Hawaii. February 13, 2006.150. "Safe & Effective Use of TCIs in Atopic Dermatitis." 30 th Annual Hawaii DermatologySeminar. Kauai, Hawaii. February 16, 2006.151. "Atopic Dermatitis Update." 30 th Annual Hawaii Dermatology Seminar. Kauai, Hawaii.February 16, 2006.152. "Treatment Strategies for Long-Term Management of Atopic Dermatitis." 30 th Annual HawaiiDermatology Seminar. Kauai, Hawaii. February 16, 2006.153. Symposium Director. Advanced Pediatric Dermatology. 2006 American Academy ofDermatology Annual Meeting. San Francisco, CA. March 3, 2006.154. "Laser Update." Pediatric Surgery Forum. 2006 American Academy of Dermatology AnnualMeeting. San Francisco, CA. March 4, 2006.155. Therapeutics in Pediatric Dermatology Symposium. 2006 American Academy of DermatologyAnnual Meeting. San Francisco, CA. March 4, 2006.156. "Classification of Vascular Birthmarks." Vascular & Pigmented Birthmarks Symposium. 2006American Academy of Dermatology Annual Meeting. San Francisco, CA. March 6, 2006.157. "Traditional Therapeutic Strategies for Atopic Eczema." Atopic Eczema & Other DermatitidesSymposium. 2006 American Academy of Dermatology Annual Meeting. San Francisco, CA.March 7, 2006.158. "Atopic Dermatitis – Bench to Bedside." 293 rd Dr. Luis Guerrero Memorial Lecturer, 21 stAnnual Postgraduate Course, University of Santo Tomas, Manila, Philippines. March 16, 2006.Page 45 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.159. "Procedural Pediatric Dermatology (Anesthesia, Analgesia, Laser & Surgical Techniques." 21 stAnnual Postgraduate Course, University of Santo Tomas, Manila, Philippines. March 16, 2006.160. "Mimics of Child Abuse." 21 st Annual Postgraduate Course, University of Santo Tomas,Manila, Philippines. March 17, 2006.161. "Birthmarks." 21 st Annual Postgraduate Course, University of Santo Tomas, Manila,Philippines. March 17, 2006.162. "Pediatric Dermatology." UCSD Department of Dermatology Resident Lecture,San Diego, CA. March 22, 2006.163. "Neonatal Dermatology." UCSD Department of Neonatology Resident Lecture,San Diego, CA. March 28, 2006.164. "Atopic Dermatitis Update." Naval Medical Center Department of Pediatrics, San Diego, CA.April 17, 2006165. "Atopic Dermatitis: From Bench to Bedside." Pediatric Dermatology for the Practitioner,Philadelphia, PA. April 21, 2006.166. "Challenging Cases for Fun." Pediatric Dermatology for the Practitioner, Philadelphia, PA.April 21, 2006.167. "Acne: What Zit All About?" Pediatric Dermatology for the Practitioner, Philadelphia, PA.April 22, 2006.------------------------------168. "Itching to Know What's New: An Update on Atopic Dermatitis from Bench to Bedside."Children's Hospital of Philadelphia 150th Symposium, Philadelphia, PA. May 5, 2006.169. "What's New in Pediatric Dermatology." American Dermatological Association 126th AnnualMeeting, Half Moon Bay, CA. July 15, 2006.170. "Barrier Dysfunction and Barrier Repair." Scientific Symposium, American Academy ofDermatology Academy '06, San Diego, CA. July 27, 2006.171. "How to Manage Pediatric Atopic Dermatitis." Symposium, American Academy ofDermatology Academy '06, San Diego, CA. July 28, 2006.172. "Very Low Gestational Age Infants: Dermatologic Perspectives." 3rd Argentinean Congress ofNeonatal Dermatology, Buenos Aires, Argentina. August 31, 2006.173. "Lasers in Neonatal Dermatology." 3rd Argentinean Congress of Neonatal Dermatology,Buenos Aires, Argentina. September 1, 2006.174. "Hemangiomas: Bench to Cribside." 3rd Argentinean Congress of Neonatal Dermatology,Buenos Aires, Argentina. September 2, 2006.175. "Pediatric Dermatology." California Society of Dermatology & Dermatologic Surgery 2006Annual Meeting, Coronado, CA. September 10, 2006.176. "Lasers in Pediatric Dermatology," and "What's New in the Treatment of Atopic Dermatitis."Irish Society of Dermatology, Dublin, Ireland. October 13, 2006.177. "Pediatric Dermatology," and "What's New in Pediatric Dermatology." Mount SinaiDepartment of Dermatology Ninth Annual Winter Symposium, New York, NY. December 9,2006.Page 46 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.178. "What's New in Pediatric Dermatology, "Dermatitis: From Top to Bottom," "Sun, Moles andSkin Cancer," and Acne Update: What's 'Zit' All About?" American Academy of PediatricsCME Course, Vail, CO. January 11-14, 2007.179. "Ask the Experts in Pediatric Dermatology" and "Ask our Experts: Strategies in Acne/AcneRoscacea Management 2007." Advances in Cosmetic and Medical Dermatology, Wailea, Maui,HI. January 17-22, 2007.180. Symposium - "Traditional Therapeutic Strategies for Atopic Eczema," Forum – "ClinicalTrials," Forum – "Laser Surgery," Symposium – "When Acne Starts Early: The Very YoungPediatric Patient," and Symposium – "Dermatologic Surgery in Pediatric Patients." AmericanAcademy of Dermatology Annual Meeting, Washington, DC.January 31-February 5, 2007.181. "Atopic Dermatology: Barrier Function, Inflammation and Atopy." Pediatrics Faculty ResearchSeminar, Rady Children's Hospital-San Diego. February 13, 2007.182. Symposium – "Therapeutic Protocols with Immunomodulators for Atopic Dermatitis," Seminar– "Use of Current and Future Biologics in the Treatment of Atopic Dermatitis," and Workshop– "Severe Atopic Dermatitis: Focus on the Infant and Toddler: Ask the Dermatologist andAllergist." American Academy of Allergy Asthma & Immunology Annual Meeting, SanDiego, CA. February 23-26, 2007.183. "Neonatal Dermatology" and "What's New in Pediatric Dermatology." New Horizons inPediatrics, Atlanta, GA. March 24, 2007.184. "Integumentary Disorders." RN/RT Residency in Pediatrics Program, Rady Children'sHospital-San Diego, San Diego, CA. April 13, 2007.185. "Dermatitis in Infants and Children" and "Pediatric Dermatology – What's New." Valley of theSun Conference, Phoenix, AZ. April 15, 2007.186. "Acne: Spotlight on the Spot," Workshop: "Diagnostic Dilemmas, Stump the Experts," andMini-Symposia: "Dermatology Crash Course" and "The Eczema Center." PediatricDermatology for the Practitioner, San Diego, CA. April 20-21, 2007.187. National Institute of Allergy and Infectious Diseases (NIAID), the American Academy ofAllergy, Asthma, and Immunology (AAAAI), and the Food Allergy and Anaphylaxis Network(FAAN). Invited Speaker, "Developing Guidelines for the Diagnosis and Management of FoodAllergies" meeting, representing the American Academy of Dermatology (AAD). NationalInstitutes of Health, Bethesda, MD. July 19, 2007.188. "Clinical Case Presentations and Panel Discussion." Pacific Dermatologic Association 59thAnnual Meeting, San Diego, CA. August 23, 2007.189. "Update on the Pathogenesis of Atopic Dermatitis," and "New Therapeutic Approaches forAtopic Dermatitis and Infections." Inflammatory Skin Disorders, Chicago, IL. September 5,2007.190. "The Moley Child," "Use of Natural Products in Atopic Dermatitis," and "Advanced MedicalAnd Surgical Therapies in Pediatric Skin Disease – When & How to Use Them." Women's &Pediatrics Dermatology Seminar, San Francisco, CA. September 29, 2007.191. "New Horizons in the Management of Atopic Dermatitis " (Symposium Co-Chair), and "SkinBarrier and Atopic Dermatitis." 21st World Congress of Dermatology, Buenos Aires,Argentina. October 4, 2007.Page 47 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.192. "Insights into Pathogenesis and Therapeutic Options," and "Neonatal Dermatology." C.S.Livingood Lecturer, Michigan Dermatological Society, Detroit, MI. October 17, 2007.193. "Advances in Pediatric Dermatology." Fall Clinical Derm Conference, Las Vegas, NV. October19, 2007.194. "Meet the Expert – Atopic Dermatitis," and "Skin Infections and Infestations" (AudienceResponse Case Discussion), American Academy of Pediatrics National Conference &Exhibition, San Francisco, CA. October 27 – 29, 2007.195. "Integumentary Disorders." RN/RT Residency in Pediatrics Program, Rady Children'sHospital-San Diego, San Diego, CA. November 30, 2007.196. "Pediatric Dermatology Update," and "Atopic Dermatitis." Mount Sinai Department ofDermatology Tenth Annual Winter Symposium, New York, NY. December 8, 2007.197. "Signs of Systemic Disease." dermBridge, Med 280, Pathophysiology of the Skin, University ofCalifornia, San Diego. San Diego, CA. January 17, 2008.198. Symposium - "Neonatal Dermatology;" Forum – "Clinical Trials;" Symposium - "PediatricTherapies;" Symposium - "Approach to the hospitalized neonate." American Academy ofDermatology Annual Meeting. San Antonio, TX. January 31 - February 4, 2008.199. "Neonatal Dermatology," and "Acne Vulgaris." dermBridge, Med 280, Pathophysiology of theSkin, University of California, San Diego. San Diego, CA. February 21, 2008.200. "Dermatitis Update," and "What's That? Approach to Neonatal Dermatology." Advances in thePractices of Pediatrics, Rady Children's Hospital, San Diego. San Diego, CA. February 22,2008.201. "Atopic Dermatitis 2008," and "Pediatric Dermatology: An Integrative Approach to CaseBased Management of Pediatric Disorders." Advances in Cosmetic and Medical Dermatology.Wailea, HI. February 28, 2008.202. Symposium Director, Clinical Update on Pediatric Dermatology. "Inflammatory Skin DiseaseUpdate," "TCIs for Dermatitis – Where, When and How," "Pediatric Vascular Anomalies," and"Naturals in Atopic Dermatitis." 32nd Annual Hawaii Dermatology Seminar. Waikoloa, HI.March 1-7, 2008.203. "Atopic Dermatitis Update" and "Neonatal Dermatology." Grand Rounds. University ofCalifornia –Davis, Department of Dermatology. Sacramento, CA. April 2, 2008.204. "Neonatal Dermatology," and "Do you have with it takes to be a Pediatric Dermatologist?"Pediatric Dermatology for the Practitioner, Philadelphia, PA. April 18, 2008.205. "Current and future treatments for eczema," and "Ongoing research – what's up doc?" The FifthAnnual Eczema Patient Conference, San Diego, CA. July 25, 2008.206. "Update on psoriasis, acne and other inflammatory skin disorders," and "Ongoing research –what's up?" Update on Eczema, Atopic Conditions, and Inflammatory Skin Disorders, SanDiego, CA. July 25, 2008.207. "Melanoma & Complicated Melanocytic Neoplasms in Pediatric Patients." Grand Rounds.University of California-San Diego, Department of Dermatology. San Diego, CA. August 28,2008.208. "Pediatric Dermatology: Neonatal Diseases." California Society of Dermatology andDermatologic Surgery. Santa Barbara, CA. September 13, 2008.Page 48 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.209. "Atopic Dermatitis – the whole story from outside-in," "Vascular lesions I kids – a medicalapproach," and "The dermatology reality show – challenging diagnostic and therapeutic cases."Women's and Pediatric Dermatology Conference. San Francisco, CA. September 20, 2008.210. "Update on Atopy, Pathogenesis & Treatment" and Fungal infections update." AAD ReviewRegional Course. Scottsdale, AZ. November 22-32, 2008.211. "Rheum with a view: dermatologic aspects of pediatric rheumatologic disease." DermatologyGrand Rounds. Loma Linda Medical Center, Loma Linda, CA. December 3, 2008.212. "Treating the Tough Ones." Advances in Cosmetic and Medical Dermatology. Wailea, HI.January 28, 2009.213. "The Newest Scoop on Acne," "Atopic Dermatitis," and "Baby Derm: Neo Update," as part ofClinical Update on Pediatric Dermatology. Skin Disease Education Foundation HawaiiDermatology. Wailea, Maui, Hawaii. February 11, 2009.214. "IVIG and SJS." General Pediatrics noon conference, Rady Children's Hospital San Diego.San Diego, CA. February 17, 2009.215. "Challenging Cases." Rady Children's Hospital Pediatric Dermatology Didactics. San Diego,CA. February 19, 2009.216. "Hemangiomas and Vascular Lesions." Rady Children's Hospital Pediatric OtolaryngologyDidactics. San Diego, CA. February 20, 2009.217. "Adolescent Dermatology," "Visual Diagnosis-Dermatology." American Academy of PediatricsFuture of Pediatrics 2009. Anaheim, CA. February 28, 2009.218. "Onychomycosis in Children," "Neonatal Dermatology," "Emerging Therapies for AtopicDermatitis/Eczema," "Pediatric Dermatology," and "Clinical Trials Forum." 67th AnnualAmerican Academy of Dermatology Meeting. San Francisco, CA. March 6-10, 2009.219. "What's New & True In Laser Therapy?" and "Advanced Pediatric Dermatology DiagnosticChallenges." Pediatric Dermatology for the Practitioner. San Diego, CA. April 17-18, 2009.220. "Neo Derm 101, 411, 911." Neonatology Case Conference, Sharp Mary Birch Hospital forWomen. San Diego, CA. May 12, 2009.------------------------------221. Plastic Surgery Grand Rounds, "Seeing Red: Hemangiomas and Vascular Malformations."University of California San Diego. San Diego, CA. July 22, 2009.222. "Atopic Dermatitis," "What's Breaking Out – Challenging Acne Cases: Childhood andAdolescence," and "What's Hot in Atopic Dermatitis." Summer Academy Meeting of theAmerican Academy of Dermatology. Boston, MA. July 30-August 2, 2009.223. "In the Beginning…There was Neonatology!" "Dermatology Jeopardy," and Rheum with aView." Women's & Pediatrics Dermatology. San Francisco, CA. September 10-13, 2009.224. Visiting Professor, Penn State College of Medicine, S. Hershey Medical Center. "NeonatalDermatology Update" and "Procedural Pediatric Dermatology." Hershey, PA. October 1, 2009.225. World Congress of Pediatric Dermatology: Atopic Dermatitis Symposium, Speaker and Chair;―Atopic Dermatitis Update.‖ Invited Lecturer, ―Opportunistic Infections in Neonates.‖Bangkok, Thailand. November 17-18, 2009.Page 49 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.226. ―Eczema Update‖ and ―What‘s New in Pediatric Dermatology‖ Mount Sinai WinterDermatology Winter Symposium. New York, NY. December 12, 2009.227. "Hot Topic – Pigmented Lesions in Kids," "Terrible to Trivial: Pediatric Version." Advancesin Cosmetic and Medical Dermatology, Wailea, Maui, HI. January 25, 2010.228. "What's Erupting: Acne Update," and "Cases for the Panel: What Would You Do?" SkinDisease Education Foundation Hawaii Dermatology. Kona, HI. February 29, 2010.229. "Acne & Rosacea Update Forum," What's New in Pediatric Dermatology," PediatricOnychomycosis/Nail Disorders," Clinical Trials in an Academic Setting and PediatricConsiderations," Neonatal Dermatology – Don't Panic!" and "Atopic and Other EczematousDermatoses." 68th Annual American Academy of Dermatology Meeting. Miami Beach, FL.March 02-09, 2010.230. "Neonatal Dermatology (a case-based overview)." Dermatology Resident Conference.University of Texas Southwestern Medical Center. Dallas, Texas. March 31, 2010.231. Pasquariello Lectureship. "Neonatal Dermatology." Dermatology Grand Rounds. Children'sHospital of Philadelphia Dermatology. Philadelphia, PA. April 14, 2010.232. "What's New in Eczema." Dermatology Grand Rounds. Mount Sinai School of Medicine. NewYork, NY. April 15, 2010.233. "Red, White, Blue and New: What's up with Hemangiomas," "Challenging Cases for Fun," and"Zit's Complicated: An Update on Acne." Pediatric Dermatology for the Practitioner.Philadelphia, PA. April 16, 2010.234. "Atopic Dermatitis: Insights into Pathogenesis and Therapy." Pediatric Grand Rounds. DukeUniversity Medical Center. Durham, NC. May 25, 2010.235. Sidbury Lecturer. "Atopic Dermatitis Insights." and "Case Presentations" for Residents.Dermatology Grand Rounds. Duke University Medical Center. Durham, NC. May 26, 2010.236. "Advances in Pediatric Dermatology – You Make the Call," "Skin Signs – When to Worry andNot to Worry," and "Case Studies in Pediatric Dermatology." 12th Annual SummerConference on Pediatrics. Napa, CA. July 6-10, 2010.237. "How Does the Academic Pediatric Dermatologist Partner w/Industry?" Society for PediatricDermatology Annual Meeting. Portland, OR. July 17, 2010.238. "Hemangiomas: What's Hot." Summer Academy Meeting of the American Academy ofDermatology. Chicago, IL. August 5-8, 2010.239. Plenary Session Speaker: "Neonatal Dermatology: Recent Developments." Summer AcademyMeeting of the American Academy of Dermatology. Chicago, IL. August 5-8, 2010240. "Increasing Patient Compliance." Update on Eczema, Asthma & Atopic Conditions. Chicago,IL. August 7, 2010.241. Pediatric Dermatology Symposium, "Seeing Red: Hemangiomas and Vascular Lesions." PacificDermatologic Association Annual Meeting. Pasadena, CA. August 12. 2010.242. "Acne." University of California San Diego Department of Medicine (Dermatology) Didactics.San Diego, CA. August 25, 2010.243. "Back-To-School Dermatology Issues." Invited speaker, Encinitas Community HealthcareForum. Encinitas, CA. August 26, 2010.Page 50 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.244. "In the Beginning…Neonatology," and "Atopic Dermatitis: Meeting the Clinical Challenge."Women's and Pediatric Dermatology Meeting. San Francisco, CA. September 25, 2010.245. "What's the Scoop on Pediatric Acne?" and "PISD? Pediatric Inflammatory Skin Disease."Coastal Derm Meeting. Rancho Bernardo, CA. October 1, 2010.246. "Dermatology – Things that Cause Rings," and "Itch and Scratch." American Academy ofPediatrics National Conference. San Francisco, CA. October 5, 2010.247. "Neonatal Dermatology." University of California San Diego Department of Medicine(Dermatology) Didactics. San Diego, CA. October 6, 2010.248. "Controversies in Dermatology," "New Developments in Atopic Dermatitis," and "TherapeuticHotline." Fall Clinical Dermatology Conference. Las Vegas, NV. October 8, 2010.249. ―In the Beginning...Neonatal Dermatology,‖ ―To Worry or Not to Worry: Visual DermatologicDiagnosis,‖ ―Topical Topics: What‘s New in Acne and Eczema Therapy,‖ and ―Scales & Nails:Fungal Infection Update.‖ American Academy of Pediatrics-CA CME Meeting. Las Vegas,NV. November 19-22, 2010.250. Paediatric Dermatology Update. Excellence in Paediatrics. London, UK. December 3, 2010.251. "‘Rheum‘ with a View," ―Food Allergy and Dermatology (‗Testing‘), Plenary Session Speaker,and ―Fungal Infections.‖ 69th Annual American Academy of Dermatology Meeting.New Orleans, LA. February 4-10, 2011.252. ―Pediatric Spots,‖ and ―Atopic Angst.‖ Advances in Cosmetic and Medical Dermatology.Maui, HI. February 25, 2011.253. ―MRSA & Others: Skin & Soft Tissue Infections,‖ and ―Case Studies in Derm: Cases that keepyou up at night!‖ 11th Annual Conference on Pediatric Emergencies. Breckenridge, CO.March 3-5, 2011.254. Session Chair, ―Clinical Update on Pediatric Dermatology,‖ ―Hot Stuff‖ in Inflammatory SkinDisease,‖ and ―What Would You Do? Cases for the Panel.‖ 35th Annual Hawaii DermatologySeminar, March 13-18, 2011.255. "Challenging Cases," and ―Acne – What‘s Erupting.‖ Pediatric Dermatology for thePractitioner. San Diego, CA. April 8-9, 2011.256. ―Skin Rashes: When do I need to Worry?‖ Advanced Pediatric Emergency Medicine AssemblyConference. San Diego, CA. April 13, 2011.257. Invited Lecturer. ―Allergy & Atopic Dermatology – NIH Food Allergy Guidelines.‖ New YorkUniversity Dermatology Grand Rounds. New York, NY. April 29, 2011.258. ―The New NIAID Food Allergy Guidelines: How do They Affect My Practice?‖ SummerAcademy Meeting of the American Academy of Dermatology. New York, NY. August 4-7,2011.259. ―Atopic Dermatitis, What‘s New?‖ Colorado Dermatologic Society. Englewood, CO.September 23, 2011.260. "Atopic Dermatitis: Meeting the Clinical Challenge,‖ and Cutaneous Challenges in YourLittlest Patients.‖ Women's and Pediatric Dermatology Conference. San Francisco, CA.September 24, 2011.Page 51 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.20. A 13-day, randomized, multi-center, investigator-blinded, parallel group pharmacokinetic,safety, and local tolerability comparison of Elidel cream 1% with tacrolimus ointment 0.1% inthe treatment of adult subjects with moderate to severe atopic dermatitis, followed by 24-weeksof treatment with Elidel cream 1% to evaluate long-term safety (Novartis CASM981C2401).21. A prospective pediatric longitudinal evaluation to assess the long term safety of tacrolimusointment for the treatment of atopic dermatitis (Astellas APPLES).22. A Randomized, Double-Blinded Study of Epiceram versus Elidel in Pediatric Subjects withMild to Moderate Atopic Dermatitis (Ceragenix).23. A Double-Blind, Randomized, Vehicle-Controlled Trial to Determine the Efficacy and Safetyof Locoid Lipocream (Hydrocortisone Butyrate 0.1%) Cream in the Treatment of Mild toModerate Atopic Dermatitis in Pediatric Subjects (Ferndale 04-110).24. A Multi-Center Study To Assess The Impact Of Topical Corticosteroids On The Safety AndEfficacy Of Protopic (Tacrolimus) Ointment In The Short-Term Treatment Of AtopicDermatitis And To Assess Protopic In The Long-Term Management Of Atopic Dermatitis(Fujiwasa 20-04-002).25. A 16-week, randomized, multi-center, parallel-group pimecrolimus-blinded, controlled study toevaluate the safety of concomitant use of pimecrolimus cream 1% (BID) plus topicalcorticosteroid (BID) for the treatment of severe atopic dermatitis in patients 2 to 17 years of age(Novartis CASM981C2439).26. An investigation of the safety and efficacy of Elidel 1% cream in atopic disease modification,assessed in a 3 year randomized, double-blind, vehicle-controlled phase to evaluate effects onAtopic Dermatitis in infants, and a 2-3 year open-label phase to evaluate the effect of earlyintervention versus delayed intervention with Elidel on the incidence of asthma in children(Novartis CASM981CUS09).27. Method Evaluation for Buccal Swab Collection. Fillagrin gene analysis and phenotypecorrelation (a substudy of Novartis CASM981C US09).28. A 5-year prospective study in infants with atopic dermatitis to determine risk factors, with afocus on pets and pests, on the development of asthma and allergic diseases (NovartisCASM981CUS26).29. A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Safety andEfficacy of 1% and 2% Nanocrystalline Silver Cream (NPI 32101) Applied Twice Daily inPediatric and Adolescent Subjects with Mild to Moderate Atopic Dermatitis (AD) (Nucryst32101-2-03).30. An Open-Label, Treatment Continuation Study of 2% Nanocrystalline Silver Cream (NPI32101) Applied Twice Daily in Children with Atopic Dermatitis who Previously Completed aDouble-Blind, Placebo-Controlled Study of NPI 32101 (Nucryst 32101-2-05).31. A Multicenter, Randomized, Vehicle-Controlled Clinical Study to Examine the Efficacy andSafety of Atopiclair in the Management of Mild to Moderate Atopic Dermatitis in Infants andChildren. (Sinclair SIN-At005).Page 54 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.32. A Multi-Center, Double-Blind, Bilateral Study to Compare the Efficacy and Safety of MimyxCream to Desonide Cream 0.05% in Reducing the Risk of Relapse in Atopic Dermatitis for 8Weeks (Steifel 0433).33. An Open-Label Safety Study Of Derma-Smoothe/FS Topical Oil In Pediatric Patients, 3Months To 2 Years Old, With Atopic Dermatitis (Hill HD-038-PED).34. A Randomized, Double-Blind, Vehicle-Controlled Study of The Safety And Efficacy OfKetoconazole Foam, 2%, Versus Teva (Ketoconazole) 2% Cream In The Treatment OfSeborrheic Dermatitis (Connetics KFD.C.005).35. A Multi-Center, Open-Label Study to Evaluate the Effect of ALTANA Inc's Cutivate®(Fluticasone Propionate) Lotion 0.05% on the Hypothalamic Adrenal Axis in the Treatment ofAtopic Dermatitis in a Pediatric Population (ALT 0434-01-01).36. To evaluate the tolerance of regimen body cleanser F#10984-018 and body cream F#10971-025in babies and children with mild to moderate atopic dermatitis (Johnson and Johnson 60951,60954.11C).37. A placebo-Controlled, Double-blind, Randomized Parallel Group Exploratory Study of theSafety and Efficacy of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis that isModerate in Severity (Johnson and Johnson/Alza C-2006-04-01).38. Evaluation of the cutaneous innate immune response to oral and topical vitamin D ($50,000grant, UCSD/RCHSD Intramural Patient-Based Research Grant Application Competition for2007).39. Clinical Evaluation of T.R.U.E. Test® Panel 1.1, 2.1, 3.1, in Children and Adolescents (Mekos07 29P1/2/3 401).40. APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety ofTarcolimus Ointment for the Treatment of Atopic Dermatitis (Astellas Pharma GlobalDevelopment Protocol 03-0-161/FG-506-06-37)41. An Open-Label Evaluation of the Adrenal Suppression Potential of AlclometasoneDipropionate Lotion 0.05% in the Treatment of Moderate to Severe Atopic Dermatitis inPediatric Subjects (Nycomed 0405-01-04)Pain Reduction42. Sedation, analgesia and anesthesia practices for cutaneous procedures in children.43. Survey of patterns of use of topical and intralesional anesthetic agents, sedatives, andanesthesia of pediatric dermatologists, and assessment of changes in patterns of use over time.44. Minimizing pain associated with cutaneous procedures in children: study of topical andintralesional agents. Assessment of efficacy of 30% lidocaine preparation, EMLA cream, andbuffered lidocaine solution for painful procedures including skin biopsies, excisions,venipuncture, subcutaneous reservoir access, laser therapy, cryotherapy and lumbar puncture,using patient/parent preference scores and visual analog scores of pain.45. A clinical study to evaluate the efficacy of ELA-MAX (4% liposmal lidocaine) as compared toEMLA cream (an eutectic mixture of local anesthetics) for pain reduction of venipuncture inchildren.Page 55 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.Cutaneous Infections in Children and Adolescents46. Epidemiology of human papillomavirus (HPV) in Anogenital warts in children ($15,000 grant,Child Abuse Prevention Foundation).47. Cotton-swab culture method for the diagnosis of tinea capitis. Comparison of cotton-tipapplicator swab cultures vs. "toothbrush" method for culture of suspected tinea capitis inchildren and adolescents.48. A randomized, double-blind, parallel group study to determine the effective duration (1, 2, or 4weeks) and safety of Lamisil® (tablets) given once daily to patients with tinea capitis due toTrichophyton species (mainly T. tonsurans).49. An open-label, multicenter, multiple-does study to evaluate the pharmacokinetics of terbinafine(Lamisil®) in children 4-8 years of age with tinea capitis. (Novartis CSF0327 W352, Part A).50. Topical 5% 5-fluorouracil cream for the treatment of verruca vulgaris of the hands in children(ICN-001-03).51. A randomized, double-blind, double-dummy, placebo-controlled study of the safety andefficacy of ketoconazole foam, 2%, vs. nizoral (ketoconazole) 2% cream in the treatment ofseborrheic dermatitis (Connetics KFD.C.002).52. Phase III Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy ofImiquimod Cream, 5% for the Treatment of Molluscum Contagiosum in Pediatric Subjects (3M1494-IMIQ).53. Phase I Pharmacokinetic Study of Imiquimod Cream, 5% in Pediatric Subjects with MolluscumContagiosum (3M 1498-IMIQ).54. A Prospective, Double-Blind, Placebo-Controlled Trial Of Topical Penlac Nail Lacquer ForTherapy Of Onychomycosis In Children (Dermik PENLAC $157,812.50).55. A Clinical Study To Evaluate The Safety And Efficacy Of Lotrimin Ultra (ButenafineHydrochloride Cream 1%) In The Treatment Of Tinea Corporis In A Pediatric Population(Schering-Plough CL2001-10).56. A Randomized, Investigator Blinded, Active-Controlled, Parallel-Group Study To CompareThe Efficacy And Safety Of 6-Week Treatment With Terbinafine New Pediatric FormulationVersus 6-Week Treatment With Griseofulvin Pediatric Suspension In Children With TineaCapitis. (Novartis CSFO327C2301).Treatment of Vascular Lesions in Infants and Children57. Treatment of functionally significant hemangiomas with systemic angiostatic agents and pulseddye laser.58. Utility of pulsed dye laser for vascular lesions in Latino patients with type IV and type V skin.59. Comparison of laserscope Orion to Candela/flashlamp pumped pulsed dye laser for thetreatment of previously treated port wine stains. Study of the performance of a 532 nm laserlight with a variable pulsed duration system, to the standard 585 nm laser light for the treatmentof port wine stains in adults and children.Page 56 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.Ichthyosis: TherapyAcne60. Phase III randomized, double-blind, parallel, placebo-controlled study to evaluate safety andefficacy and rollover open label study to evaluate long-term safety of glyorin in treatment ofnon-bullous congenital ichthyosiform erythroderma.61. A double-blind, randomized, placebo-controlled multicenter study to assess two strengths oftretinoin microsphere gel in the treatment of moderate acne vulgaris.62. A double-blind, randomized vehicle-controlled, multicenter study to assess the safety andefficacy of tretinoin microsphere gel 0.4% in the treatment of acne vulgaris.63. An open-label study to evaluate the effect of a single course of Accutane® therapy on bonemineral density in pediatric patients with severe, recalcitrant, nodular acne.64. A multi-center, phase 3, randomized, double-blind, 4-arm clinical trial to compare the safetyand efficacy of Clin-RA Gel vs. Clindamycin Phosphate 1.2% vs. Tretinoin 0.025% gel vs.Clin-RA Gel vehicle in the treatment of acne vulgaris. (Dow Pharmaceuticals 7001.G2HP-07-02).65. A randomized, double-blind, double-dummy, vehicle-controlled study of the safety andefficacy of Clindamycin phosphate foam, 1%, vs. clindagel (Clindamycin phosphate gel)topical gel, 1%, for the treatment of acne (Connetics CLN.C.003).66. The P.U.M.P. Study: Patients Using MICRO Properly; An Open-label, Community Based,Phase Four Study to Assess Facial Acne Improvement with Use of RETIN-A MICRO®(Tretinoin Gel) Microsphere, 0.04% or 0.1% in a Pump Dispenser (Johnson and Johnson CA-P-4056).67. A Phase III, Multi-Center, Randomized, Double-Blind, Vehicle- Controlled, 4-Arm, ParallelGroup Comparison Study Comparing the Efficacy and Safety of Clindaben (1/2.5), ClindabenVehicle, Clindamycin (1%), and Benzoyl Peroxide (2.5%) Gels in the Treatment of Moderateto Severe Acne Vulgaris (Dow DPSI-06-22-2006-012)68. A Phase 3, Randomized, Double-Blind, Multi-Dose Study to Evaluate the Safety and Efficacyof 5% Dapsone Topical Gel, (DTG 5%) When Co-Administered with Vehicle Control,Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% in the Treatment of Acne Vulgaris (QLTDAP0407).69. A multi-Center, Investigator-Blind, Randomized Study to Evaluate the Safety, Tolerability andEfficacy of ClenzIderm M.D. vs. BenzaClin® Topical Gel in the Treatment of Mild toModerate Facial Acne Vulgaris (Obagi NOA 10).70. A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacyand Safety of Adapalene Lotion, 0.1% Compared with Vehicle Lotion in Subjects with AcneVulgaris (Galderma RD.SPR.06.18114).71. A Phase 2B Multi-Center, Double-Blind, Randomized, Dose-Ranging Clinical Trial to EvaluateIDP-107 in the Treatment of Moderate to Severe Acne Vulfatis with Nodular Involvement(Dow DPSI-IDP-P2-01).Page 57 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.72. An Investigator-Blinded, Randomized, Community, Based, Phase Four Study to Assess FacialAcne Improvement and Tolerability with Use of RETIN-A MICRO® (Tretinioin Gel)Microsphere, 0.04% in a Pump Dispenser in a Pediatric Population (Johnson andJohnson/OrthoNeutrogena).73. Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel associated withDoxycycline Hyclate 100 mg capsules in the Treatment of Severe Acne Vulgaris (GaldermaRD.03.SPR.29074).74. An Evaluation of a 6-month Maintenance with Adapalene 0.1%/Benzoyl Peroxide 2.5%/Gelversus Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel Vehicle Gel in the Treatment of AcneVulgaris (Galderma RD.03.SPR.29075).75. A Phase 3 MultiCenter, Randomized, Double-blind, Active and Vehicle-controlled study fo thesafety and efficacy of Duac Low-Dose Gel versus Clindamycin Gel versus Benzoyl PeroxideGel versus Vehicle gel in subjects with acne vulgaris (Stiefel W0261-301).76. A Multi-Center, Double-Blind, Vehicle Controlled, Study of Retin-A Micro 0.04% in theTreatment of Pediatric Acne Vulgaris in Children, Ages 9 to 11 Years of Age (Johnson &Johnson Study B0285S)77. A multi-center, randomized, vehicle-controlled, double-blind study to evaluate the safety andefficacy of Epiduo (adapalene and benzoyl peroxide) Gel 0.1%/2.5% administered once dailyfor the treatment of subjects 9 to 11 years of age with acne vulgaris (GaldermaRD.06.SPR.18155)78. A Multi-Center, Double-Blinded, Vehicle Controlled, Phase II Study of JNJ 10229570-AAAfor the Treatment of Acne Vulgaris (Johnson & Johnson, CA-P-8023-1 Phase II)Nevi, Melanoma, Skin Cancer, and Photoprotection79. A randomized, double-blind, multicenter clinical study to test the safety and efficacy of T4N5liposome lotion on patients with xeroderma pigmentosum in the protection against actinickeratoses.80. Children's sun block safety in-use test. Neutrogena Corporation. Two independent studies.81. Sun safety intervention for postal carriers. Investigator/Consultant. National Cancer Institute.1/01-1/05 ($2.7 million).82. Promoting sunscreen at the point of purchase. Investigator/Consultant. National CancerInstitute. 4/99-3/02 ($701,194).83. Promoting solar protection among zoo visitors. Investigator/Consultant. Centers for DiseaseControl and Prevention. 9/97-9/00 ($834,070).84. Sunwise programming by aquatics teachers and pharmacists. Investigator/Consultant. NationalInstitute for Arthritis and Musculoskeletal and Skin Diseases. 4/94-3/99 ($1.1 million).85. Performance of Epilumescence Digital Imaging of atypical NEVI with clinical-histopathologiccorrelation (Cindy Matters Grant $19,000.00).Page 58 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.86. A Randomized, Double-Blind, Comparative, Crossover study to Evaluate the Tolerance andEfficacy of SS Baby Sunblock Lotion SPF 60, 1321-126 to a Commercial Benchmark Productin Babies and Children (Neutrogena).87. A double blinded, prospective, randomized, stratified, placebo-controlled, multi-center study ofphotodynamic therapy with Visonac cream in patients with moderate to severe acne vulgaris(Photocure PCTA30409)Psoriasis88. Placebo-controlled, Multi-center Study with Etanercept to Determine the Safety and Efficacy inPediatric Subjects with Plaque Psoriasis (PEDS) (Amgen 20030211).89. An Open-label Extension Study to Evaluate the Safety of Entanercept in Pediatric Subjects withPlaque Psoriasis (Amgen 20050111).90. A Phase 3, Randomized, Double-Blind Study To Evaluate The Efficacy And Safety Of TwiceDaily Tacrolimus Cream-B 0.1% Versus Cream Vehicle In The Treatment Of Psoriasis(Astellas 04-0-205).91. PK and PD of Calcitriol Following Twice Daily Application of Calcitriol 3µg/g Ointment underConditions of Maximal Use on Adolescents with Plaque Psoriasis (GaldermaRD.06.SPR.18102).92. Effect of Calcipotriol plus Betamethasone Dipropionate Toical Suspensio on the HPA Axis andCalcium Metabolism in Adolescent Subjects (Aged 12 to 17 Years) with Scalp Psoriasis. PIand International Coordinator.93. A Phase 2, Single-Arm Study to Evaluate the Safety and Pharmacokinetics of Alefacept inAdolescent Subjects with Moderate to Severe Psoriasis (Amevive/Clinsys Protocol 0485-CL-0004)94. Safety and efficacy of TACLONEX ointment in adolescent patients (aged 12 to 17 years) withpsoriasis vulgaris (Leo Pharma Health Solutions MCB 0502 INT)95. An Open-label Extension Study to Evaluate the Safety of Etanrecept in Pediatric Subjects withPlaque Psoriasis (Amgen 20050111)96. Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children andAdolescents with Psoriasis (Amgen 20080414)97. Effect of Calcipotriol plus Betamethasone dipropionate Topical Suspension on the HPA axisand calcium metabolism in adolescent patients (aged 12 to 17 years) with scalp psoriasis (LEOPharmaceutical Products MBL 0801)98. A Multicenter, Randomized, Vehicle-controlled, Double-blind, Parallel group Study ofEfficacy and Safety of CD2027 2µg/g Topical Aerosol Applied Twice Daily for 8 Weeks inSubjects with Plaque-type Psoriasis (Galderma RD.06.SPR.18178)Miscellaneous99. A Multi-Center, Open-Label Study of the Safety and Efficacy of Repeated Treatments withBOTOX Purified Neurotoxin Complex for Primary Axillary Hyperhidrosis in Adolescents(Allergan 191622-075-00).Page 59 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.100. A Randomized, Double-Blind, Placebo-Controlled, Dose Response Study for the Safety andEfficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa(RegeneRx SSEB).Page 60 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.MENTOREES: CLINICAL (C) & RESEARCH (R) FELLOWS (AND PRESENT POSITIONS)2012-2013Reagan Hunt (c)Cynee DeKlotz (c)Kathy Langevin (c)Shehla Admani (r)Clinical FellowClinical FellowClinical FellowResearch FellowMichael Osofsky (c)Tina Chen (c)Andrew Krakowski (c)Caroline Piggott (c)Michael Caglia (r)2010-2011David Dasher (c)Melinda Jen (c)Melissa Reyes Merin (c)Chika Ugorji (r)2009-2010Kristen Hook (c)Sarah Hill (c)Shireen Guide (c)Private Practice, Oshkosh, WI. Academic appointment pending.Sharp Health Care, San Diego, CAAssistant Professor of Pediatrics & Medicine (Dermatology), Universityof California, San Diego, School of Medicine; Pediatric & AdolescentDermatology, Rady Children's Hospital, San Diego (full-time academicposition)Scripps Clinic, San Diego, CAResearch Fellowship & Dermatology Residency, University of Utah, SaltLake City, UTAlmance Dermatology,Burlington, NCAssistant Professor of Pediatric Dermatology, University ofPennsylvania; Pediatric Dermatology, Children‘s Hospital ofPhiladelphiaKaiser Permanente, Los Angeles, CAPrivate Practice, Poughkeepsie, NYAssistant Professor, Department of Dermatology, University ofMinnesota, Minneapolis, MN; Pediatric Dermatology, University ofMinnesota Children‘s Hospital, Amplatz (full-time academicposition)Consultant Dermatologist, Department of Dermatology, WaikatoHospital, Hamilton, and Rotorua Hospital, Rotorua, New ZealandMission Dermatology, San Clemente, CACatalina Matiz (r) Dermatology Resident – 1 July, 2010 – June 30, 2013Kendra Gillis (r)2008-2009Allison Swanson (c)Children‘s Hospital of AlabamaAssistant Professor of Pediatrics and Dermatology. Children‘sMercy Medical Center and University of Kansas School ofPage 61 of 69

Curriculum VitaeAugust 2012Sarah Hill (c)Catalina Matiz (r)Alexandra McCollum (r)2007-2008Sara Dill (c)Wynnis Tom (c)Andrew Krakowski (r)Manju Kalavala (r)2006-2007Joseph Lam (c)Andrew Krakowski (r)Mei-Lin Pang (r)Alessandra Alio (r)Kevin Boyd (r)Angela Medina (r)2005-2006Christine Kilcline (c)Carla Lee (c)Mei-Lin Pang (r)Alessandra Alio (r)Stephanie Kelter-Folgelson (r)MedicineClinical Fellow – First yearResearch FellowLawrence F. Eichenfield, M.D.Private Practice, Pediatrics. Long Island, New York.Assistant Professor of Dermatology and Residency ProgramDirector, Department of Dermatology, Brown University Schoolof Medicine, Rhode IslandAssistant Professor of Pediatrics & Medicine (Dermatology),University of California, San Diego, School of Medicine; Pediatric& Adolescent Dermatology, Children's Hospital, San Diego (fulltimeacademic position)Dermatology ResidentUniversity of California, San Diego School of MedicineSchool of Postgraduate Medical and Dental Education, CardiffUniversity, Cardiff, UK: Staff PhysicianAssistant Clinical Professor, Department of Dermatology,University of British Columbia; Vancouver, CanadaResearch FellowClinical Dermatology Fellowship, University of California SanFranciscoStiefel Research InstituteClinical Fellowship, University of Alabama, BirminghamPrivate Practice – Manila, PhilippinesPrivate Practice – Vallejo, CAAssistant Professor of Dermatology and Pediatrics, VanderbiltMedical School, Nashville, TNResearch FellowResearch Fellow – Third yearDermatology Resident, Loma Linda UniversityPage 62 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.2004-2005Brandi J. Metz (formerly Roberts)(c)Robert L. Buka (c)Asad Salim (c)July 1 – October 11, 2004Alessandra Alio (r)Marcia Hogeling (r)Assistant Professor of Pediatrics and Medicine; Chief, PediatricDermatology, University of California, Irvine (full-time academicposition)Clinical Instructor, Pediatric Dermatology, Mount Sinai School ofMedicine, New York; Director of Pediatric and AdolescentDermatology, The Dermatology Group, Verona, NJConsultant Dermatologist, Mid-Staffordshire General Hospital,Staffordshire, UKResearch Fellow – Second yearDermatology Resident, University of Ottawa, Ontario, Canada2003 – 2004Cheryl Barnes (c)Elizabeth Connelly (c)Alessandra Alio (r)Associate Professor, Department of Dermatology, MedicalCollege of Georgia (full-time academic position)Assistant Clinical Professor, Department of Dermatology andPediatrics, Division of Pediatric Dermatology, University ofMiami School of Medicine (full-time academics)Research Fellow2002-2003Kimberly Morel (c)Catherine Maari (c)Yuin Chew Chan (c)Tsippora Shainhouse (r)Assistant Professor of Clinical Dermatology and ClinicalPediatrics, Columbia University and Morgan Stanley Children'sHospital of New York-Presbyterian (full-time academic position)Clinical Instructor, Department of Dermatology, CHUM and Ste-Justine Hospital, Montreal University Hospital Center (full-timeacademic position)Chief of Pediatric Dermatology, National Skin Centre; VisitingAssociate Consultant, KK Women's and Children's Hospital;Clinical Tutor, National University of Singapore (full-timeacademic position); Vice President, Singapore DermatologySocietyCompleted Pediatric Residency; Dermatology Residency SUNYStony Brook, New York2002-2001Valerie Lyon (c)Magdalene Dohil (c)Associate Professor, Northwestern University; Assistant ClinicalProfessor, Medical College of Wisconsin (full-time academicposition)Associate Clinical Professor of Pediatrics & Medicine(Dermatology), University of California, San Diego, School ofMedicine; Pediatric & Adolescent Dermatology, Children'sHospital, San Diego (full-time academic position)Page 63 of 69

Curriculum VitaeAugust 2012Laurie Bernard (r)Lawrence F. Eichenfield, M.D.Assistant Clinical Professor of Pediatrics, University of California,San Diego, School of Medicine; Children's Hospital, San Diego*Note: Pediatric Hospitalist2001-2000James Bergman (c)Sami Al-Suwaidan (c)Clinical Assistant Professor of Medicine, Division ofDermatology, University of British ColumbiaChairman, Department of Dermatology; Assistant Professor ofDermatology; Consultant, Pediatric Dermatology & LaserSurgery, College of Medicine, King Saud University (full-timeacademic position)1999-2000Judy Williams (c)Associate Professor of Pediatrics and Dermatology, EasternVirginia Medical School; Director of Dermatology, Children'sSpecialty Group, Norfolk, VA (full-time academic position)David Opai-Tetteh (r) (Part-Time) Staff Dermatologist, New Image Creations Dermatology;Sherman Oaks, CA1997-1999Neil Gibbs (c)Assistant Clinical Professor of Pediatrics and Medicine(Dermatology), University of California, San Diego, School ofMedicine; Dermatology Residency Program Director, NavalMedical Center, San Diego1996-1997Francisco Colon-Fontanez (c)Associate Professor of Dermatology, University of Puerto RicoSchool of Medicine, San Juan; Director of Dermatology,University Hospital, Carolina; Pediatric Dermatologist, San JorgesChildren's Hospital, San Juan, Puerto RicoPage 64 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.MENTOREES: RESIDENTS & MEDICAL STUDENTSAndrea Munden, MS 3Jessica Hsu, MS 3Pam Chayavichitsilp, MS 3Chelsea Hodgkiss-HarlowCharles ChiangMember, ISP CommitteeResearch Fellowship – 2008-2009 (One-Year NIH Training Grant inClinical Research) and ISP CommitteeResearch Fellowship – 2007-2008 (One-Year NIH Training Grant inClinical Research) and ISP CommitteeISP ChairISP ChairCathy Macknet, M.D. Women's Dermatologic Society Mentorship Program – 2006Justine Yun, M.D. Women's Dermatologic Society Mentorship Program – 2005Leslie Storey, M.D. Women's Dermatologic Society Mentorship Program - 2004MENTOREES: POST-GRADUATE (AMERICAN ACADEMY OF DERMATOLOGY)John Browning University of Texas Health Science Center - 2008PRECEPTORSHIPS: OTHERPreceptor, Dermatologic Surgery Preceptorship Program – American Society for Dermatologic Surgery –2004; 2006; 2007Page 65 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.ADDENDUM:RECENT CONTRACTS AND GRANTSTitlePerformance of Epilumescence Digital Imaging of atypical NEVIwith clinical-histopathologic correlation.Phase I Pharmacokinetic Study of Imiquimod Cream, 5% inPediatric Subjects with Molluscum ContagiosumAn Open-Label Safety Study of Derma-Smoothe/FS Topical Oil inPediatric Patients, 3 Months to 2 Years Old, with AtopicDermatitisA randomized clinical Trial Comparing Tissue Adhesive (2-Octylcyanoacrylate) vs. Absorbable Suture vs. Non-AbsorbableSuture for the Closure of Low Tension Facial and Neck Wounds inChildren and Adolescents (Dermabond Study)Cathelicidin Expression LL-37 in Hemangiomas of Infancy andCapillary MalformationsA Double-Blind, Randomized, Vehicle-Controlled Trial toDetermine the Efficacy and Safety of Locoid Lipocream Cream inthe Treatment of Mild to Moderate Atopic Dermatitis in PediatricSubjectsA Randomized, Double-Blind, Placebo-controlled, Parallel-GroupStudy of the Safety and Efficacy of 1% and 2% NanocrystallineSilver Cream Applied Twice Daily in Pediatric Subject with Mildto Moderate Atopic DermatitisA Randomized, Double-Blind, Vehicle-Controlled Study of theSafety and Efficacy of Ketoconazole Foam, 2%, versus Teva(Ketoconazole) 2% Cream in the Treatment of SeborrheicDermatitisA 5-year prospective study in infants with atopic dermatitis todetermine risk factors, with a focus on pets and pests, on thedevelopment of asthma and allergic diseasesPlacebo-controlled, Multi-center Study with Etanercept toDetermine the Safety and Efficacy in Pediatric Subjects withPlaque PsoriasisAn investigation of the safety and efficacy of Elidel 1% cream inatopic disease modification, assessed in a 3 year randomized,double-blind, vehicle-controlled phase to evaluate effects onAtopic Dermatitis in infants, and a 2-3 year open-label phase toevaluate the effect of early intervention versus delayedintervention with Elidel on the incidence of asthma in childrenA Randomized, Investigator-Blinded, Active-Controlled, Parallel-Group Study to Compare the Safety and Efficacy of 6 WeekTreatment with Terbinafine New Pediatric Formulation versus 6Week Treatment with Griseofulvin Pediatric Suspension inChildren with Tinea CapitisA Multi-center Study to Assess the Impact of TopicalCorticosteroids on the Safety and Efficacy of Protopic(Tacrolimus) Ointment in the Short Term Treatment of AtopicDermatitis and to Assess Protopic in the Long Term Managementof Atopic DermatitisA Prospective, Double-Blinded, Placebo-Controlled Trial ofTopical Penlac Nail Lacquer For Therapy of Onychomycosis inChildrenA Multi-Center, Double-Blind, Bilateral Study to Compare theEfficacy and Safety of Mimyx Cream to Desonide Cream 0.05%in Reducing the Risk of Relapse in Atopic Dermatitis for 8 WeeksGranting AgencyCindy MattersFoundationAmount of TotalAward (includeindirect costs)19,0003M 96,815Hill Dermaceuticals 118,153InvestigatorInitiatedDermatologyFoundation (Grant)FerndaleLaboratoriesNone45,00026,831Nucryst 162,388Connetics 9,139NovartisPharmaceuticalsAmgenNovartisPharmaceuticalsNovartisPharmaceuticals89,002Time periodofcontract/grantMay 06 –Aug 07Mar 04 – Dec06Mar 04 – Dec06Jul 04 – Dec06Sep 05 – Jul06Oct 05 – Dec06Nov 05 – Jul06Dec 05 – Dec06Dec 05 – Dec0993,199 Nov 04 – Dec06570,00047,138Astellas 24,000Dermik 100,000Steifel Laboratories 69,063Oct 03 – Dec09Jul 04 – Jul06Feb 05 – Dec06Jul 02 – Mar06May 05 – Jan06Role, e.g.PI, coinvestigator, projectleader, etc.PIPISub-ISub-ISub-IPIPISub-IPIPIPISub-IPIPIPIPage 66 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.A Preliminary Investigation of the Safety Profile of Mederma forPediatric UseA Clinical Study to Evaluate the Safety and Efficacy of LotriminUltra (Butenafine Hydrochloride Cream 1%) in the Treatment ofTinea Corporis in a Pediatric PopulationA Clinical Study to Evaluate the Efficacy of Tracrolimus Ointment0.1% for the Treatment of Keratosis PilarisA Phase III, Randomized, Double-blind, Multi-Dose Study toEvaluate the Safety and Efficacy of 5% Dapsone Topical Gel,(DTG 5%) When Co-Administered with Vehicle Control,Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% in theTreatment of Acne VulgarisAn Open-Label Study to Evaluate the Safety of Desonide Foam,0.05%, Including its Effect on the Hypothalamic Pituitary AdrenalAxis of Adolescent and Pediatric SubjectsA Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of Desonide Foam,0.05% in the Treatment of Adolescent and Pediatric Subjects withMild to Moderate Atopic DermatitisPhase III Vehicle-controlled, Double-blind Study to Assess theSafety and Efficacy of Imiquimod Cream, 5% for the Treatment ofMolluscum Contagiosum in Pediatric SubjectsA Safety Study of a Topical Corticosteroid Cream in PediatricSubjects Aged 3 Years to 5 Years 11 Months with AtopicDermatitisA Safety Study of a Topical Corticosteroid Cream in PediatricSubjects Aged 3 Months to 35 Months with Atopic DermatitisSafety and Efficacy of Taclonex Ointment in Adolescent Patients(Aged 12-17 Years) with Psoriasis VulgarisA Multi-Center, Double Blind, Vehicle Controlled, Study ofRetin-A Micro® 0.04% in the Treatment of Pediatric AcneVulgaris in Children, Ages 9 to 11 Years of AgeAPPLES: A Prospective Pediatric Longitudinal Evaluation toAssess the Long-Term Safety of Tacrolimus Ointment for theTreatment of Atopic Dermatitis.A Phase 2, Single-Arm Study to Evaluate the Safety andPharmacokinetics of Alefacept in Adolescent Subjects withModerate to Severe PsoriasisClinical Evaluation of T.R.U.E. TEST® Panel 1.1, 2.1, and 3.1: inChildren and AdolescentsAn Open-label Study to Assess Facial Acne Improvement andTolerability with Use of Retin-A Micro (Tretinoin Gel)Microsphere, 0.4% in a Pump Dispenser in a Pediatric PopulationMerz 59,000Schering-Plough 29,585Fujisawa, Inc.(Grant)30,000QLT USA, Inc. 24,450Connetics 50,668Connetics 90,1323M 54,320GlaxoSmithKline 13,200GlaxoSmithKline 19,350LEO Pharma 52,440Johnson & Johnson 69,745Astellas 78, 000Astellas 128, 639Allerderm 139, 545Johnson & Johnson 166, 068Jan 05 –closed toenrollmentSep 04 – Oct05Oct 03 – Oct05Mar 05 – Jan06Jul 04 – Sep05Oct 04 – Sep05Jun 04 – Nov05Nov 04 – Jun05Nov 04 – Jun05May 09 –EnrollingMarch 09 –EnrollingAug 05 –Closed toEnrollmentFeb 09 –EnrollingAug 08 –EnrollingMarch 08 –Closed toEnrollmentPISub-ISub-IPIPIPIPIPIPIPIPIPIPIPIPIA Phase 3 Multi-Center, Randomized, Double-Blind, Active andVehicle-Controlled study of the safety and efficacy of Duac LowdoseGel versus Clindamycin gel versus benzoyl peroxide gelversus vehicle gel in subjects with acne vulgarisAn Open-Label Extension Study to Evaluate the Safety ofEtanercept in Pediatric Subjects with Plaque PsoriasisPharmacokinetics and Pharmacodynamics of Calcitriol FollowingTwice Daily Application of Calcitriol 3ug/g Ointment underConditions of Maximal Use in Adolescents with Plaque Psoriasis.A Double-Blind, Randomized, Placebo-Controlled, SequentialCohort Exploratory Study of the Safety and Efficacy of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis that isModerate in SeverityA 5-Year, Prospective Study in Infants with Atopic Dermatitis toDetermine Risk Factors, with a Focus on Pets and Pests, on theStiefel 161, 444Amgen 167, 868Galderma 129, 307Johnson & Johnson 153, 714NovartisPharmaceuticals7,890Nov 08 –EnrollingNov 05 –Closed toEnrollmentApril 06 –EnrollingNov 06 –April 09Dec 05 –Closed toPIPIPIPIPIPage 67 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.Development of Asthma and Allergic Diseases (Sub-study ofCASM981CUS09).A Randomized, Double-Blind, Placebo-Controlled, Dose-rangingStudy of the Safety and Efficacy of Thymosin Beta 4 in theTreatment of Patients With Epidermolysis BullosaA Phase 2B Multi-Center, Double-Blind, Randomized, Dose-Ranging Clinical Trial to Evaluate IDP-107 in the Treatment ofModerate to Severe Acne Vulgaris With Nodular InvolvementAn Evaluation of the Cutaneous Innate Immune and ClinicalResponse to Oral and Topical Vitamin D in Subjects with AtopicDermatitisRegeneRx 56, 019Dow 23, 000Intramural ClinicalResearch Funding50,000EnrollmentSep 07 –EnrollingSep 06 – Sep07Oct 07 –EnrollingPIPIPIEfficacy and Safety comparison of Adapalene 0.1% BenzoylPeroxide 2.5% Gel versus Adapalene 0.1% Benzoyl Peroxide2.5% Gel Vehicle Gel as a 6-month Acne Maintenance Treatment29074 Efficacy and Safety comparison of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel associated with Doxycycline Hyclate100 mg Tablets versus Adapalene 0.1% / Benzoyl Peroxide 2.5%Vehicle Gel associated with Doxycycline Hyclate 100 mg Tabletsin the Treatment of Severe Acne Vulgaris29074 Efficacy and Safety comparison of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel associated with Doxycycline Hyclate100 mg Tablets versus Adapalene 0.1% / Benzoyl Peroxide 2.5%Vehicle Gel associated with Doxycycline Hyclate 100 mg Tabletsin the Treatment of Severe Acne VulgarisDevelopment of an "Eczema Area and Severity Index" teachingmoduleVideo Training Modules for Atopic Dermatitis EducationA randomized, controlled multidose, multicenter, adaptive phaseII/III study in infants with proliferating infantile hemangiomasrequiring systemic therapy to compare four regimens ofpropranolol (1 or 3 mg/kg/day for 3 or 6 months) to placebo(double blind)Evaluation of the Cutaneous Innate Immune and Clinical Responseto Oral and Topical Vitamin DMethod Evaluation for Buccal Swab Collection - A sub-study ofCASM981C US09A Phase 2, single-arm study to evaluate the Safety andPharmacokinetics of Alefacept in Adolescent Subjects withmoderate to Severe PsoriasisGalderma 11,589Galderma 45,704Galderma 45,704AsubioPharmaceuticalsAmerican Academyof DermatologyProgram forInnovative MedicalEducation inDermatology(PICMED)Pierre FabreDermatologieUCSD/CSSD/RCHSD Intramural Grant12,50015,000254,53750,000Novartis 18,175Astellas Pharma 72,000Aug 08 –EnrollingJuly 08 –April 09July 08 –April 09Jan 08 – Jul08Jan 08 – Dec0711/09 -present08/2007 –06/201110/2007 –06/201012/2008 –presentPIPIPIProjectLeadPISub-IPIPIPIA Multi-Center, Double-Blind, Vehicle Controlled, Study ofRetin-A Micro 0.04% in the Treatment of Pediatric Acne Vulgarisin Children, Ages 9 to 11 Years of AgeJohnson & Johnson 19,372March 09 -OngoingPICross-sectional Evaluation of Biological Markers ofCardiovascular Disease in Children and Adolescents with PsoriasisSafety and Efficacy of TACLONEX Ointment in AdolescentPatients (aged 12 to 17 years) with Psoriasis vulgarisA double-blind, prospective, randomized, stratified, placebo-Controlled, multi-center study of photodynamic therapy withVisonac cream in patients with moderate to severe acne vulgarisEffect of Calcipotriol plus Betamethasone dipropionate TopicalSuspension on the HPA axis and calcium metabolism inadolescent patients (aged 12 to 17 years) with scalp psoriasisInvestigator-Initiated/Amgen1332500Leo Pharma 71,820PhotoCure ASA 63,053Leo Pharma 145,00008/2009 –Present05/2009 –present09/2009 –05/201005/2010 –presentPIPIPIPIPage 68 of 69

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.A multi-center, randomized, vehicle-controlled, double-blind studyto evaluate the safety and efficacy of Eipduo (adapalene andbenzoyl peroxide) Gel 0.1%/2.5% administered once daily for thetreatment of subjects 9 to 11 years of age with acne vulgarisGalderma 122,50706/2010-presentPIEffect of Calcipotriol plus Betamethasone dipropionate TopicalSuspension on the HPA axis and calcium metabolism inadolescent patients (aged 12 to 17 years) with scalp psoriasisLEOPharmaceuticalProducts18,522Jun 10 –OngoingPIAn Open-Label Evaluation of the Adrenal Suppression Potential ofAlclometasone Dipropionate Lotion 0.05% in the Treatment ofModerate to Severe Atopic Dermatitis in Pediatric SubjectsNycomed 20,419Jan 11 -OngoingPIA Multi-Center, Double-Blinded, Vehicle Controlled, Phase IIStudy of JNJ 10229570-AAA for the Treatment of Acne Vulgaris;Protocol CA-P-8023-2 Phase IIJohnson & Johnson 114,680Systemic Therapies for Pediatric Atopic Dermatitis None NoneMolecular Insights into Pediatric Psoriasis Pathogenesis NIH – NIAMS 661,500(PC TA 206/11) A double blinded, prospective, randomized,vehicle controlled multi-center study of photodynamic therapywith Visonac® cream in patients with acne vulgarisCharacterization of Genotype, Virulence, and Microfloral Balanceof Staph Aureus Strains Causing Infection in Children with AtopicDermatitis versus ControlsA comparative study with Coats Whole Leaf Aloe Vera® creamand over-the counter 1% hydrocortisone cream for treatment ofmild to moderate atopic dermatitis in pediatric patients 6 months to17 years of ageA Phase 1, Open-Label, Multicenter Study to Evaluate the Safety,Tolerability, Pharmacodynamics, and Pharmacokinetics ofCalcipotriene Foam, 0.005%, Applied Under Maximal-UseConditions in Adolescent Subjects (Ages 12 to 16 Years) withPlaque Psoriasis [Clinical Study Protocol: STF 115750]Photocure 70,000Society for PediatricDermatologyCoats AloeInternationalStiefel Laboratories(GSK)20,000161,43847,000Topical timolol gel for the treatment of infantile hemangiomas Valeant 75,00003/2011-06/201203/2011-06/202107/2011-06/201605/2011-08/201207/2011-07/201201/2012-06/201302/2012-06/201301/2012-01/2014PISub-ISub-IPISub-IPIPISub-IPage 69 of 69